Personale

Recapiti

Italiano

Curriculum

Pubblicazioni

Insegnamenti

Teresita MAZZEI

Ruolo attuale:: Professore Ordinario in Pensione
SSD:: BIO/14 - Farmacologia
Afferenza organizzativa:: Dipartimento di Scienze della Salute (DSS)

Recapiti

teresita.mazzei(AT)unifi.it

Teresita MAZZEI

Curriculum

Studi compiuti

1967 Diploma di Maturità classica, Liceo Classico F.Petrarca, Arezzo
1973 Laurea in Medicina e Chirurgia, Facoltà di Medicina e Chirurgia, Università di Firenze

1977 Diploma di Specializzazione, Scuola di Specializzazione in Ostetricia e Ginecologia, Università di Firenze

1979               Diploma di Specializzazione, Scuola di Specializzazione in Oncologia, Università di Modena

Posizioni accademiche

1975-1977   Titolare di assegno biennale di formazione didattica e scientifica, Facoltà di Medicina e Chirurgia, Cattedra di Chemioterapia, Istituto di Farmacologia, Università di Firenze

1977-1983   Assistente di ruolo, Facoltà di Medicina e Chirurgia, Cattedra di Chemioterapia, Istituto di Farmacologia, Università di Firenze

1983-1990 Professore Associato di Chemioterapia, Facoltà di Medicina e Chirurgia, Dipartimento di Farmacologia Preclinica e Clinica, Università di Firenze

Dal 01.11.90 Professore Straordinario di Chemioterapia, Facoltà di Medicina e Chirurgia, Dipartimento di Farmacologia Preclinica e Clinica, Università di Firenze

Dal 01.11.93   Professore Ordinario di Chemioterapia, Facoltà di Medicina e Chirurgia, Dipartimento di Farmacologia Preclinica e Clinica, Università di Firenze

2016-2017 Coordinatore Master di II Livello su "SALUTE E MEDICINA DI GENERE", Dipartimento di Scienze della Salute, Università degli Studi di Firenze

Altre posizioni non accademiche

1996-1997 Esperto della Commissione Unica del Farmaco. Ministero della Sanità

1996-2001 Consulente per la Chemioterapia dell’Ospedale Civile di Empoli (USL 11, Regione Toscana)

Dal gennaio 1997 Tesoriere Ordine dei Medici Chirurghi e Odontoiatri di Firenze

Dal giugno 1998 Membro della Commissione Oncologica Regionale

Dal 2004    Membro della Commissione Terapeutica Regionale Toscana

2005-2007   Segretario Generale della Società Internazionale di Chemioterapia

Dal 2005   Vice Presidente della Società Italiana di Chemioterapia

Dal 2007   Segretario Generale e Presidente Eletto della Società Internazionale di Chemioterapia

Soggiorni all’estero

1985-1986        Honorary Clinical Assistent, Department of Oncology and Radiotherapy, Westminster Hospital, Londra

Appartenenza a Società Scientifiche

Dal 1975 Società Italiana di Chemioterapia

Dal 1976 Associazione Italiana di Oncologia Medica

Dal 1981 Membro del Consiglio Direttivo della Società Italiana di Chemioterapia

Dal 1982 Società Italiana di Farmacologia

Dal 1985 Associazione Italiana di Immunofarmacologia

Dal 1987 Surgical Infection Society

1989 – 1999 Segretario e Tesoriere della Società Italiana di Chemioterapia

1993 - 1997 Membro del Consiglio Direttivo della Associazione Italiana di
Immunofarmacologia

Dal 1996 Membro ”American Society of Clinical Oncology”

Dal 1996 Membro del Consiglio Direttivo della Società Italiana di Infettivologia
Otorinolaringoiatrica

1997–2002 Membro del Consiglio Direttivo della Società Italiana di Microbiologia

1997–2001 Membro del Consiglio Direttivo del Collegio Italiano di Farmacologia

1999-2003 Presidente Società Italiana Chemioterapia

Dal 1999   Membro del Consiglio Direttivo Società Internazionale Chemioterapia

Dal 2000   Membro del Consiglio Direttivo della Federazione delle Società Europee di Chemioterapia

2003–2007 Membro del Consiglio Direttivo della Società Italiana di Farmacologia

Attività Editoriale

1977-1981 Chemioterapia Oncologica (Redattore Capo)

1978-1981 Chemioterapia Antimicrobica (Redattore Capo)

Dal 1980 Biological Research in Pregnancy (Membro dell’Editorial Board)

Dal 1984 Farmaci & Terapia (Membro dell’Advisory Board)

Dal 1987 Chemioterapia (J.Chemotherapy) (Editore Associato)

Dal 1991 Journal of Chemotherapy (Editore)

Dal 1994 Pharmacological Research (Editore per il Settore della Chemioterapia)

Attività di Referee

- International Scientific Cooperation Program - Health and Biomedical Science

- International Journal of Feto-Maternal Medicine, ECOMED

- Drugs, ADIS International Ltd.

- Trends in Experimental and Clinical Medicine, Forum, Scuola Superiore Oncologia e Scienze Biomediche, Genova, Scuola Internazionale di Oncologia e Medicina Sperimentale, Roma

- Pharmacological Research

Teresita MAZZEI

Pubblicazioni

Legenda

Contributo su rivista |

Articolo su libro |

Libro |

Contributo in atti di convegno (proceeding) |

Brevetto |

Curatela | Altro

Altro |

Tesi di Dottorato

Mini E.; Lapucci A.; Perrone G.; D'Aurizio R.; Napoli C.; Brugia M.; Landini I.; Tassi R.; Picariello L.; Simi L.; Mancini I.; Messerini L.; Magi A.; Pinzani P.; Mazzei T.; Tonelli F.; Nobili S. (2019). RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy. INTERNATIONAL JOURNAL OF CANCER, pp. 0-0, ISSN:0020-7136, Wiley-Liss Inc.: DOI Accesso ONLINE all'editore

Villanucci A, Tavella K, Vannini L, Rossi V, Nobili S, Amunni G, Mazzei T, Mini E (2018). Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors. MOLECULAR AND CLINICAL ONCOLOGY, vol. 9, pp. 635-639, ISSN:2049-9450 DOI

Mini E., Nobili S., Mazzei T. (2017). Farmaci antineoplastici - Antimetaboliti. In: Vari. Farmacologia – Principi di base e applicazioni terapeutiche - III edizione, pp. 854-869 Edizioni Minerva Medica, ISBN:978-88-7711-881-3.

Mini E, Nobili S, Mazzei T (2017). Farmaci antineoplastici: Farmaci antiormonali.. In: Vari. Farmacologia – Principi di base e applicazioni terapeutiche - III edizione, pp. 878-886 Edizioni Minerva Medica, ISBN:978-88-7711-881-3.

Purrello, Sm; Garau, J; Giamarellos, E; Mazzei, Teresita; Pea, F; Soriano, A; Stefani, Stefania (2017). Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, vol. 7, pp. 178-186, ISSN:2213-7165 DOI

Tavella, K; Villanucci, A; Vannini, L; Rossi, V; Fantechi, B; Capone, G; Putignano, A L; Gensini, F; Porfirio, B; Amunni, G; Mazzei, T; Mini, E; Papi, L (2017). Retrospective analysis of 77 patients with ovarian cancer undergoing genetic testing for BRCA1 and BRCA2 mutations. ANNALS OF ONCOLOGY, vol. 28, pp. 71-71, ISSN:0923-7534 DOI

Galiulo M, Convertino I, Blandizzi C, Tassi R, Diacciati S, Nobili S, Capogrosso Sansone A, Marino A, Mini E, Mazzei T, Vannacci A, Parrilli M, Corona T, Tuccori M (2017). Adverse drug reactions in oncoLogy: intEnsive monitoring program on drug toXicity of biotechnological medicatioNs anD taRget therapies in Oncologic patientS - the ALEXANDROS observational study. DRUG SAFETY, vol. 40, pp. 993-993, ISSN:0114-5916 DOI

Mini E, Nobili S, Mazzei T (2017). Farmaci antineoplastici - Farmaci inibitori della trasduzione del segnale - Farmaci inibitori di protein chinasi. In: Vari. Farmacologia – Principi di base e applicazioni terapeutiche - III edizione, pp. 889-902, Torino: Edizioni Minerva Medica, ISBN:978-88-7711-881-3.

Blasi, F; Concia, E; Del Prato, B; Giusti, M; Mazzei, Teresita; Polistena, B; Rossi, Alessandro; Stefani, Stefania; Novelli, Andrea (2017). The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach.. JOURNAL OF CHEMOTHERAPY, vol. ..., pp. 1-13, ISSN:1973-9478 DOI

Nobili S, Mini, E, Mazzei T, Vannacci A (2017). Adverse drug reactions in oncoLogy: intEnsive monitoring program on biotechnological anD taRget therapies in Oncologic patientS-ALEXANDROS observational study. DRUG SAFETY, vol. 40, pp. 993-993, ISSN:0114-5916

Mini E., Nobili S., Novelli A., Mazzei T. (2017). Farmaci antimicrobici - Glicopeptidi. In: Vari. Farmacologia – Principi di base e applicazioni terapeutiche - III edizione, pp. 737-745, Torino: Edizioni Minerva Medica, ISBN:978-88-7711-881-3.

Mini E, Nobili S, Mazzei T (2017). Farmaci antineoplastici - Farmaci inibitori della trasduzione del segnale - Generalità. In: Vari. Farmacologia – Principi di base e applicazioni terapeutiche - III edizione, pp. 887-889, Torino: Edizioni Minerva Medica, ISBN:978-88-7711-881-3.

Mercadante S; Marchetti P; Cuomo A; Caraceni A; Mediati RD; Mammucari M; Natoli S; Lazzari M; Dauri M; Airoldi M; Azzarello G; Bandera M; Blasi L; Cartenì G; Chiurazzi B; Costanzo BVP; Degiovanni D; Fusco F; Guardamagna V; Iaffaioli V; Liguori S; Lorusso V; Mameli S; Mattioli R; Mazzei T; Melotti RM; Menardo V; Miotti D; Moroso S; De Santis S; Orsetti R; Papa A; Ricci S; Sabato AF; Scelzi E; Sofia M; Tonini G; Aielli F; Valle A; Caruselli A; Prestia G; Giusti R; Costanzi A; Angelini S; Iacono D; Mazzuca F; Carnevale A; Bonome P; Nicosia L; Scaringi C; Montalto A; Russo G; Forte CA; Esposito G; Bracchi P; Zecca E; Campa T; Grecchi S; Pigni A; Sammaro A; Dodaro L; Ballerini G; Vellucci R; Caldarulo C; Palombo E; Diviza M; Gianfelice V; Silvestri C; Finocchi S; Contu V; Fora G; Pedani F; Icardi M; Bellini E; Celano A; Berardo R; Ostellino O; Sartori K; Demartini P; Scroccaro R; Boscolo G; Sartori D; Rosetti F; Artioli G; Borgato L; Bertoldero G; Veronese B; Vallini I; Tuzi A; Bolzacchini E; Pinotti G; Alù M; Usset A; Arcuri C; Laudani A; Pepe A; Scagliarini S; Sgarlata MSM; Raimondi M; Valenti SMG; Bucceri A; Kasa A; Budel P; Caramellino A; Ballarino P; Donelli E; Silvestro S; Tonetti R; Bozzoni S; Cocquio A; Romano C; Nappi A; Silvestro L; De Divitiis C; Ghidoni S; Cortinovis R; Marchesi R; Fortis M; Palermo L; Pisanu GM; Carboni M.ak; Meloni F.ak; Barillari D.ak; Imperatori L.ak; Grilli G.ak; Laici G.ak; Diacciati S.ak; Petreni P; Samolsky Dekel B; Marsigli F; Manfreda M; Ghedini S; Bruno E; Salvini E; Gerboni D; Saulle S; Carella R; Pascoletti G; Bolzonello S; Bonotto M; Ellero S; Fasola G; Ongaro E; Borghesi C; Germani L; De Ruvo E; Marchetti F; Pasquale M; Masu L; Tammaro D; Saracco E; Di Dato MT; Ferrara M; Pironti A; Buonavolontà P; Ginocchi L; Musettini G; Antonuzzo A; Caparello C; Lucchesi M; Farnesi A; Zampieri M; Pisciotta M; Fioroni I; Ratta R; Cursano MC; Santini D; Potestà C; Gallo G; Saber B; (2017). Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS). ADVANCES IN THERAPY, vol. 34, pp. 120-125, ISSN:0741-238X DOI

Tavella, K; Villanucci, A; Vannini, L; Lavacchi, D; Montelatici, S; Amunni, G; Mazzei, T (2017). Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin. ANTI-CANCER DRUGS, vol. 28, pp. 465-468, ISSN:0959-4973 DOI

Mini E, Nobili S, Mazzei T (2017). Farmaci antineoplastici - Farmaci immunoterapici - Anticorpi monoclonali inibitori dei checkpoints immunitari. In: Vari. Farmacologia – Principi di base e applicazioni terapeutiche - III edizione, pp. 908-910, Torino: Edizioni Minerva Medica, ISBN:978-88-7711-881-3.

Tassi, R.; Mini, E.; D'Aurizio, R.; Perrone, G.; Magi, A.; Lapucci, A.; Napoli, C.; Picariello, L.; Brugia, M.; Landini, I.; Mazzei, T.; Tonelli, F.; Nobili, S. (2016). D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy. ANNALS OF ONCOLOGY, vol. 27, pp. iv43-iv43, ISSN:0923-7534 DOI

Mini E, Nobili S, Novelli A, Mazzei T (2016). GLICOPEPTIDI. In: Vincenzo Cuomo, Carlo Riccardi, Francesco Rossi. Farmacologia. Principi di base e applicazioni terapeutiche, pp. 737-744, Torino: Edizioni Minerva Medica spa, ISBN:9788877118813.

Tassi, R; Mini, E; D'Aurizio, R; Perrone, G; Magi, A; Lapucci, A; Napoli, C; Picariello, L; Brugia, M; Landini, I; Mazzei, T; Tonelli, F; Nobili, S (2016). Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy. ANNALS OF ONCOLOGY, vol. 27, pp. 43-43, ISSN:0923-7534 DOI

Novelli A, Fallani S, Mini E, Mazzei T (2016). AMINOGLUCOSIDI. In: Vincenzo Cuomo, Carlo Riccardi, Francesco Rossi. Farmacologia. Principi di base e applicazioni terapeutiche, pp. 715-724, Torino: Edizioni Minerva Medica spa, ISBN:9788877118813.

Mini, E; D’Aurizio, R; Perrone, G; Magi, A; Lapucci, A; Tassi, R; Napoli, C; Picariello, L; Landini, I; Brugia, M; Mazzei, T; Tonelli, F; Nobili, S (2016). A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy. ANNALS OF ONCOLOGY, vol. 27, pp. 575-575, ISSN:0923-7534 DOI

Novelli A, Cassetta MI, Mini E, Mazzei T (2016). FLUOROCHINOLONI. In: Vincenzo Cuomo, Carlo Riccardi, Francesco Rossi. Farmacologia. Principi di base e applicazioni terapeutiche, pp. 725-726, Torino: Edizioni Minerva Medica spa, ISBN:9788877118813.

Cai, T; De Nunzio, C; Salonia, A; Pea, F; Mazzei, T; Concia, E; Battaglia, M; Mirone, V (2015). Urological infections due to multidrug-resistant bacteria: what we need to know?. UROLOGIA, vol. 11, pp. 1-5, ISSN:0391-5603

Cecchin, E; Giodini, L; Buonadonna, A; Berretta, M; De Paoli, A; Scalone, S; Miolo, G; Mini, E; Nobili, S; Mazzei, T; Lonardi, S; Zagonel, V; Pella, N; Fasola, G; Tirelli, U; Montico, M; Roncato, R; Toffoli, G (2015). Pre-emptive pharmacogenetic testing implementation for chemotherapy dosage optimization: the translational experience at CRO of Aviano.. ANNALS OF ONCOLOGY, vol. 26, pp. 151-151, ISSN:0923-7534 DOI

Tassi, R; Perrone, G; Brugia, M; Simi, L; Petreni, P; Mori, E; Landini, I; Pazzagli, M; Mazzei, T; Mini, E; Nobili, S (2015). Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors.. ANNALS OF ONCOLOGY, vol. 26, pp. 43-44, ISSN:0923-7534 DOI

Rosanna, Abbate; Bruni, Vincenzina; Buselli, Rodolfo; Tommaso, Mariarosa Di; Fisher, Alessandra D.; Gensini, Gianfranco; Maggi, Mario; Mazzei, Teresita; Villari, Donata (2015). Gender-related health in tuscany. In: R. Abbate, C amador, L Aversa, S. Baccetti, S. BAgatti, D. BAgattini, L. Baggiani, C. Baggiore, A. Baldasseroni, E. Balocchini,.A. Barchiello, S. Bartolacci, V. barletta, D. Bartolozzi, A. Becorpi. A. Berti, S. Biagi, F. Bianchi, ML. Brandi, S. Bravi, V. BRuni, S. bucciantini, Donata Villari. Gender-related health in tuscany, pp. 113-115 Agenzia regionale di sanità della Toscana, ISBN:978-88-909279-0-4.

Cecchin E; Perrone G; Nobili S; Polesel J; De Mattia E; Zanusso C; Petreni P; Lonardi S; Pella N; D'Andrea M; Errante D; Rizzolio F; Mazzei T; Landini I; Mini E; Toffoli G. (2015). MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin. PHARMACOGENOMICS JOURNAL, vol. 14, pp. 219-225, ISSN:1470-269X DOI

Maria Luisa Brandi; Helen Casale; Giovanni Castellini; Luisella Cianferotti; Mariarosaria Di Tommaso; Alessandra D. Fisher; Barbara Giomi; Mario Maggi; Teresita Mazzei; Simone Parri; Salvatore Seminara; Stefano Stagi; Zelinda Tredici; Giuliano Zuccati; (2014). Comportamenti sessuali e contraccezione. In: Rosanna Abbate, Carolina Amador, Laura Aversa, Sonia Baccetti, Sara Bagatti, Daniela Bagattini Lorella Baggiani, Cristiana Baggiore, Alberto Baldasseroni, Emanuela Balocchini,Alessandro Barchielli, Simone Bartolacci, Valentina Barletta, Dario Bartolozzi, Angelamaria Becorpi, Alice Berti, Sonia Biagi, Fabrizio Bianchi, Maria Luisa Brandi, Stefano Bravi, Vincenzina Bruni, Sandra Bucciantini, Rodolfo Buselli, Rachele Capocchi, Helen Casale, Giovanni Castellini, Anna Maria Celesti, Elisabetta Chellini, Fiorella Chiappi, Luisella Cianfer, Francesco Cipriani, Emanuele Crocetti, Monica Da Frè, Alessandro Del Debbio, Mario Di Fiorino, Mariella Di Stefano, Mariarosaria Di Tommaso, Valeria Dubini, Cristina Epifani, Massimo Fabbiani, Eleonora Fanti, Natalia Faraoni, Paolo Fedi, Alessandra D. Fisher, Paolo Francesconi, Flavia Franconi, Sara Gallicchio, Gian Franco Gensini Barbara Giomi, Roberta Giommi, Lisa Gnaulati, Elisa Gualdani,Francesco Innocenti, Francesco Lapi, Isabella Lapi, Claudia Livi, Stefania Losi, Silvia Maffei, Luca Maggi, Mario Maggi, Paola Magneschi, Paola Mantellini, Andrea Martini, Teresita Mazzei,Nadia Olimpi, Linda Pannocchia, Antonio Panti, Simone Parri, Valentina Pedani, Adriano Peris, Federica Pieroni, Laura Policardo, Monia Puglia, Matilde Razzanelli, Elio Rossi, Franca Rusconi, Giuseppe Seghieri, Salvatore Seminara, Caterina Silvestri, Stefano Stagi, Donatella Talini, Caterina Teodori, Zelinda Tredici, Paola Trotta, Lucia Turco, Cristina Vassalle, Donata Villari, Fabio Voller, Giuliano Zuccati, Alfredo Zuppiroli. La salute di genere in Toscana, pp. 285-289, Regione TOSCANA: ARS Ed.

Edwards, B; Andini, R.; Esposito, S.; Grossi, P.; Lew, D.; Mazzei, T.; Novelli, A.; Soriano, A.; Gould, I.M. (2014). Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now?. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, vol. 2, pp. 133-140, ISSN:2213-7165 DOI Accesso ONLINE all'editore

Mazzei T; Diacciati S. (2014). Pharmacological aspects of the antibiotics used for urological diagnostic procedures. JOURNAL OF CHEMOTHERAPY, vol. 26 Suppl 1, pp. S24-S34, ISSN:1973-9478 DOI

Concia E; Mazzei T; Azzini AM; Diacciati S; Franco M; Mirone V. (2014). Therapeutic recommendations of the multidisciplinary group.. JOURNAL OF CHEMOTHERAPY, vol. 26 Suppl 1, pp. S36-S38, ISSN:1973-9478 DOI

Bassetti M; Righi E; De Pascale G; De Gaudio R; Giarratano A; Mazzei T; Morace G; Petrosillo N; Stefani S; Antonelli M. (2014). How to manage aspergillosis in non-neutropenic intensive care unit patients.. CRITICAL CARE, vol. 18, pp. 458-469, ISSN:1364-8535 DOI

Mazzei T (2013). PK-PD of antifungal drugs: from preclinical data to clinical applications. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 42, pp. S7-S7, ISSN:0924-8579

Tambyah, Paul Anantharajah; Hara, Gabriel Levy; Daikos, George L.; Falagas, Matthew E.; Mazzei, Teresita; Mouton, Johan W.; Novelli, Andrea; Chen, Baiyi; Wang, Minggui; Ko, Wen-Chien; Li, Taisheng; Fan, Xinjian; Theuretzbacher, Ursula (2013). Treatment of extensively drug-resistant Gram-negative infections in critically ill patients: Outcome of a consensus meeting at the 13th Asia-Pacific Congress of Clinical Microbiology and Infection, October 2012. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, vol. 1, pp. 117-122, ISSN:2213-7165 DOI

Bal, A.M; Garau, J.; Gould, I.M.; Liao, C.H.; Mazzei, T.; Nimmo, G.R.; Soriano, A.; Stefani, S.; Tenover, F.C. (2013). Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: End of an era?. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, vol. 1, pp. 23-30, ISSN:2213-7165 DOI

Nobili S; Landini I; Mazzei T; Mini E (2012). Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression. MEDICINAL RESEARCH REVIEWS, vol. 32, pp. 1220-1262, ISSN:0198-6325 DOI

Bassetti M;De Gaudio R;Mazzei T;Morace G;Petrosillo N;Viale P;Bello G;La Face S;Antonelli M (2012). A survey on infection management practices in Italian ICUs.. CRITICAL CARE, vol. 16, pp. 1-2, ISSN:1364-8535 DOI

I.M. Gould; M.Z. David; S. Esposito; J. Garau; G. Lina; T. Mazzei; G. Peters (2012). New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 39, pp. 96-104, ISSN:0924-8579

Bassetti M; De Gaudio R; Mazzei T; Morace G; Petrosillo N; Viale P; Bello G; La Face S; Antonelli M (2012). A survey on infection management practices in Italian ICUs. CRITICAL CARE, vol. 15, pp. R221-0, ISSN:1466-609X DOI

I.M. Gould; R. Cauda; S. Esposito; F. Gudiol; T. Mazzei; J. Garau (2011). Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 37, pp. 202-209, ISSN:0924-8579

T. Mazzei (2011). The difficulties of polytherapy: examples from antimicrobial chemotherapy. INTERNAL AND EMERGENCY MEDICINE, vol. 6, pp. 103-109, ISSN:1828-0447

Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E (2011). Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer. INTERNATIONAL JOURNAL OF CANCER, vol. 128, pp. 1935-1945, ISSN:0020-7136 DOI

M. Vignoli; S. Nobili; C. Napoli; A.L. Putignano; M. Morganti; L. Papi; R. Valanzano; F. Cianchi; F. Tonelli; T. Mazzei; E. Mini; M. Genuardi. (2011). Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil. PHARMACOLOGICAL RESEARCH, vol. 64, pp. 242-248, ISSN:1043-6618 DOI

Blasi, F; Concia, E; Mazzei, T; Moretti, A M; Nicoletti, G; Novelli, A; Tempera, G (2010). Pharmacological and pharmaeconomic considerations. JOURNAL OF CHEMOTHERAPY, vol. 22, pp. 14-24, ISSN:1120-009X DOI

Blasi, F.*; Concia, E.; Mazzei, T.; Moretti, A.M.; Nicoletti, G.; Novelli, A.; Tempera, G.; GIARIR, null (2010). Conclusions. Role of the oral Beta-lactams in the treatment of exacerbations of chronic bronchitis: critical analysis and therapeutics recommendations. JOURNAL OF CHEMOTHERAPY, vol. 22, pp. 25-28, ISSN:1973-9478

T. Mazzei (2010). The pharmacokinetics and pharmacodynamics of the carbapenems: focus on doripenem. JOURNAL OF CHEMOTHERAPY, vol. 22, pp. 219-225, ISSN:1120-009X

Lapi F;Tuccori M;Motola D;Pugi A;Vietri M;Montanaro N;Vaccheri A;Leoni O;Cocci A;Leone R;Conforti A;Moretti U;Sessa E;Mazzaglia G;Mugelli A;Mazzei T;Vannacci A (2010). Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy.. DRUG SAFETY, vol. 33, pp. 789-799, ISSN:0114-5916 DOI

F. Blasi; E. Concia; T. mazzei; A.M. Moretti; G. Nicoletti; A. Novelli; G. Tempera; GIARIR (2010). Role of the oral Beta-lactams in the treatment of exacerbations of chronic bronchitis: critical analysis and therapeutics recommendations. JOURNAL OF CHEMOTHERAPY, vol. 22, pp. 3-30, ISSN:1120-009X

G.C. Schito; L. Gualco; K.G. Naber; H. Botto; J. Palau; T. Mazzei; A. Marchese (2010). Do Different susceptibility breakpoints affect the selection of antimicrobials for treatment of uncomplicated cystitis?. JOURNAL OF CHEMOTHERAPY, vol. 22, pp. 345-355, ISSN:1120-009X

Novelli A; Fallani S; Mini E; Mazzei T. (2010). Chemioterapici Antimicrobici – Aminoglucosidi.. In: F. Rossi, C. Riccardi, V. Cuomo. Farmacologia - Principi di base e applicazioni terapeutiche, pp. 649-660, Torino: Edizioni Minerva Medica, ISBN:9788877116994.

Mini E.; Nobili S.; Mazzei T. (2010). Farmaci Antineoplastici - Farmaci antiormonali. In: F. Rossi, C. Riccardi, V. Cuomo. Farmacologia - Principi di base e applicazioni terapeutiche, pp. 788-795, Torino: Edizioni Minerva Medica, ISBN:9788877116994.

Novelli A; Cassetta MI; Arrigucci S; Mini E; Mazzei T (2010). Chemioterapici Antimicrobici – Fluorochinoloni. In: F. Rossi, C. Riccardi, V. Cuomo. Farmacologia - Principi di base e applicazioni terapeutiche, pp. 660-672, Torino: Edizioni Minerva Medica, ISBN:9788877116994.

Mini E.; Nobili S.; Mazzei T. (2010). Farmaci Antineoplastici - Farmaci inibitori della trasduzione del segnale. In: F. Rossi, C. Riccardi, V. Cuomo. Farmacologia - Principi di base e applicazioni terapeutiche, pp. 797-806, Torino: Edizioni Minerva Medica, ISBN:9788877116994.

Mini E.; Nobili S.; Novelli A.; Mazzei T (2010). Chemioterapici Antimicrobici - Glicopeptidi. In: F. Rossi, C. Riccardi, V. Cuomo. Farmacologia - Principi di base e applicazioni terapeutiche, pp. 672-679, Torino: Edizioni Minerva Medica, ISBN:9788877116994.

Mazzei T; Novelli A; Mini E; Periti P. (2010). Chemioterapici Antimicrobici – Penicilline, cefalosporine ed altre -lattamine. In: F. Rossi, C. Riccardi, V. Cuomo. Farmacologia - Principi di base e applicazioni terapeutiche, pp. 626-639, Torino: Edizioni Minerva Medica, ISBN:9788877116994.

Mini E.; Nobili S.; Mazzei T. (2010). Farmaci Antineoplastici - Antimetaboliti. In: F. Rossi, C. Riccardi, V. Cuomo. Farmacologia - Principi di base e applicazioni terapeutiche, pp. 767-776, Torino: Edizioni Minerva Medica, ISBN:9788877116994.

Blasi, F; Concia, E; Mazzei, T; Moretti, A M; Nicoletti, G; Novelli, A; Tempera, G (2010). Etiology issues and problems of antibiotic resistance. JOURNAL OF CHEMOTHERAPY, vol. 22, pp. 8-13, ISSN:1120-009X DOI

Blasi, F; Concia, E; Mazzei, T; Moretti, A M; Nicoletti, G; Novelli, A; Tempera, G (2010). Description of the disease and diagnostic and epidemiologic aspects. JOURNAL OF CHEMOTHERAPY, vol. 22, pp. 4-7, ISSN:1120-009X DOI

Schito GC; Naber KG; Botto H; Palou J; Mazzei T; Gualco L; Marchese A. (2009). The ARESC study: an international urvey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 34, pp. 407-413, ISSN:0924-8579 DOI

E.CECCHI; F. LAPI; A. VANNACCI; G.BANCHELLI; T. MAZZEI; A.MUGELLI (2009). Increased levels of CA 125 and CA 19·9 serum tumour markers following cyclic combined hormone replacement therapy. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, vol. 34, pp. 129-132, ISSN:0269-4727

Vignoli M; Nobili S; Napoli C; Putignano AL; Morganti M; Papi L; Valanzano R; Cianchi F; Tonelli F; Mazzei T; Mini E; Genuardi M (2009). Influence of TYMS expression and genotype on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil. EUROPEAN JOURNAL OF HUMAN GENETICS, vol. 17 (suppl 2), pp. 187-187, ISSN:1018-4813

Vignoli M; Nobili S; Napoli C; Putignano AL; Morganti M; Papi L; Valanzano R ; Cianchi F; Tonelli F; Mazzei T; Genuardi M; Mini E. (2009). Influence of TYMS gene expression and genotype on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil. ANNALS OF ONCOLOGY, vol. 20 (Suppl 8), pp. viii124-viii125, ISSN:0923-7534

Mini E; Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Mazzei T. (2009). Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer. ANNALS OF ONCOLOGY, vol. 20 (Suppl 8), pp. viii122-viii123, ISSN:0923-7534

F. Scaglione; E. Bertazzoni Minelli; A. De Sarro; S. Esposito; D. Legnani; T. Mazzei; E. Mini; D. Passali; F. Pea ; S. Stefani; I. Viano; A. Novelli (2009). The Charta of Milan: basic criteria for the appropriate and accurate use of antibiotics:recommendations of the Italian Society of Chemotherapy. JOURNAL OF CHEMOTHERAPY, vol. 21, pp. 475-481, ISSN:1120-009X DOI

T . Mazzei; A.Novelli (2009). Pharmacological properties of antifungal drugs with afocus on anidulafungin.. DRUGS, vol. 69 Suppl 1, pp. 79-90, ISSN:0012-6667 DOI

Mazzei, Teresita*; Novelli, Andrea; Arrigucci, Silvia (2009). Farmacologia degli antibiotici nelle infezioni della cute e dei tessuti molli. LE INFEZIONI IN MEDICINA, vol. 17, pp. 37-57, ISSN:1124-9390 Accesso ONLINE all'editore

S.Arrigucci; A.Garcea; S.Fallani; M.I.Cassetta; G.Canonico; F.Tonelli; T.Mazzei; A.Novelli (2009). Ertapenem peritoneal fluid concentrations in adult surgical patients.. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 33, pp. 371-373, ISSN:0924-8579 DOI

T. Mazzei;A. Novelli (2009). Pharmacological rationale for antibiotic treatment of intra-abdominal infections.. JOURNAL OF CHEMOTHERAPY, vol. 21 Suppl 1, pp. 19-29, ISSN:1120-009X DOI

Adembri C;Fallani S;Cassetta MI;Arrigucci S;Ottaviano A;Pecile P;Mazzei T;De Gaudio R;Novelli A (2008). Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 31, pp. 122-129, ISSN:0924-8579 DOI

S.Fallani; S.Arrigucci; M.I.Cassetta; T.Mazzei; A.Novelli (2008). Valutazione dell'attività farmacodinamica in vivo di fosfomicina nei confronti di Escherichia coli. FARMACI & TERAPIA, vol. 3-4, pp. 23-30, ISSN:0393-9693

S. Nobili; D. Checcacci; F. Filippelli; S. Del Buono; V. Mazzocchi; T. Mazzei; E. Mini (2008). Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic Acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy.. JOURNAL OF CHEMOTHERAPY, vol. 20, pp. 622-631, ISSN:1120-009X

Napoli C, Nobili S, Morganti M, Landini I, Cianchi F, Valanzano R, Tonelli F, Mazzei T, Mini E (2008). Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer. In: International Symposium on Cancer genotypes and Cancer phenotypes, Florence, Italy, Luglio 4-5, 2008, -, pp. 62-62.

Kurt G Naber; Giancarlo Schito; Henry Botto; Juan Palou; Teresita Mazzei (2008). Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.. EUROPEAN UROLOGY, vol. 54, pp. 1164-1175, ISSN:1828-6569 DOI

G. Schito; P. Marchisio; L. Bellussi; T. Mazzei (2007). [Beta-lactam antibiotics: when and how in acute otitis media and pharyngotonsillitis]. PEDIATRIA MEDICA E CHIRURGICA, vol. 29, pp. 293-308, ISSN:0391-5387

T. Mazzei (2006). Serious infections treated in hospital: the contribution of clinical pharmacology. JOURNAL OF CHEMOTHERAPY, vol. 18 (Cong Rep 2), pp. 102-103, ISSN:1120-009X

A. TEMPESTINI; B. CACIAGLI; M. MORGANTI; E. WITORT; S. NOBILI; L. PAPUCCI; N. SCHIAVONE; M. DONNINI; I. LANDINI; A. LAPUCCI; F. PERNA; M. LULLI; T. MAZZEI; A. SOBRERO; E. MINI; S. CAPACCIOLI (2006). MOLECULAR CHARACTERIZATION OF ESTABLISHED HUMAN COLON CARCINOMA CELL LINES (HCT-8) MADE RESISTANT TO 5-FLUOROURACIL BY DIFFERENT SELECTION SCHEDULES. ONCOLOGY RESEARCH, vol. 16, pp. 143-156, ISSN:0965-0407, Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: asianfo@elsevier.com, tcb@elsevier.co.UK, INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010:

T. Mazzei (2006). How pharmacokinetic-pharmacodynamic (PK-PD) parameters influence antibiotic use. JOURNAL OF CHEMOTHERAPY, vol. 20 (Cong. Rep. 2), pp. 19-21, ISSN:1120-009X

T.MAZZEI;M.I.CASSETTA;S.FALLANI;S.ARRIGUCCI;A.NOVELLI (2006). Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 28 supp 1, pp. S35-S41, ISSN:0924-8579, Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598: DOI

T. Mazzei (2006). The role of clinical pharmacology. JOURNAL OF CHEMOTHERAPY, vol. 18 (Ceng. Rep. 2), pp. 75-76, ISSN:1120-009X

E. Mini; S. Nobili; B. Caciagli; I. Landini; T. Mazzei (2006). Cellular pharmacology of gemcitabine.. ANNALS OF ONCOLOGY, vol. 17 Suppl 5, pp. 7-12, ISSN:0923-7534 DOI Accesso ONLINE all'editore

S.ESPOSITO;S.NOVIELLO;G.D'ERRICO;G.MOTTA;D.PASSALI;C.AIMONI;S.PILUCCHI;S.FALLANI;M.I.CASSETTA;T.MAZZEI;A.NOVELLI (2006). Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients.. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 57 (4), pp. 789-792, ISSN:0305-7453, Oxford University Press:Journals Department, Great Clarendon Street, Oxford OX2 6DP United Kingdom:011 44 1865 556767, EMAIL: jnlorders@oup.co.uk, INTERNET: http://www.oup.co.uk, Fax: 011 44 1865 267485: DOI

Mazzei T, Mini E, Novelli A (2006). Professor Piero Periti 1921-2005. JOURNAL OF CHEMOTHERAPY, vol. 18, pp. 123-123, ISSN:1120-009X DOI

E. Mini; S. Nobili; T. Mazzei (2005). Farmaci antineoplastici - Farmaci antiormonali. In: F. Rossi, V. Cuomo, G. Riccardi. Farmacologia - Principi di base e applicazioni terapeutiche, pp. 713-720, Torino: Edizioni Minerva Medica, ISBN:9788877114976.

E. Mini; S. Nobili; T. Mazzei (2005). Farmaci antineoplastici - Farmaci inibitori della trasduzione del segnale. In: F. Rossi, V. Cuomo, C. Riccardi. Farmacologia - Principi di base e applicazioni terapeutiche, pp. 722-726, Torino: Edizioni Minerva Medica, ISBN:9788877114976.

Di Filippo A;Cammelli R;Novelli A;Mazzei T;Tonelli F;Fallani S;Cassetta MI;Messeri D;De Gaudio AR (2005). Intraoperative positive fluid balance improves tissue diffusion of ceftizoxime.. CHEMOTHERAPY, vol. 51, pp. 51-56, ISSN:0009-3157 DOI

Pinto C, Di Fabio F, Gentile AL, Mini E, Giaquinta S, Rojas Llimpe FL, Mutri V, Piana E, Mazzei T, Martoni A (2005). ADVANCED COLORECTAL CANCER (ACRC) IN ELDERLY PATIENTS: EVALUATION OF THREE DIFFERENT OXALIPLATIN-BASED CHEMOTHERAPY REGIMENS - Session D: Colo-rectal Cancer. ANNALS OF ONCOLOGY, vol. 16, pp. vii47-vii47, ISSN:0923-7534 DOI

A.NOVELLI;C.ADEMBRI;P.LIVI;S.FALLANI;T.MAZZEI;A.R.DE GAUDIO (2005). Pharmacokinetic evaluation of meropenem and imipenem in critically-ill patients with sepsis.. CLINICAL PHARMACOKINETICS, vol. 44 (5), pp. 539-549, ISSN:0312-5963 DOI

M. CORONNELLO; G. CICIANI; E. MINI; G. GUERRINI; B. CACIAGLI; S. SELLERI; A. COSTANZO; T. MAZZEI (2005). Cytotoxic activity of 3-nitropyrazolo[5,1-c][1,2,4]benzotriazine derivatives: a new series of anti-proliferative agents.. ANTI-CANCER DRUGS, vol. 16, pp. 645-651, ISSN:0959-4973 DOI

Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E (2005). Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers. EUROPEAN JOURNAL OF CANCER, vol. 41, pp. 2176-2183, ISSN:0959-8049 DOI

E.Mini; S.Nobili; A.Novelli; T.Mazzei (2005). Glicopeptidi. In: F.Rossi, V.Cuomo, C.Riccardi. Farmacologia: principi di base e applicazioni terapeutiche, pp. 611-618, Torino.: Edizioni Minerva Medica., ISBN:9788877114976.

A.Novelli; M.I.Cassetta; E.Mini; T.Mazzei (2005). Fluorochinoloni.. In: F.Rossi, V.Cuomo, C.Riccardi.. Farmacologia: principi di base e applicazioni terapeutiche, pp. 600-610, torino: Edizioni Minerva Medica, ISBN:9788877114976.

A.Novelli; S.Fallani; E.Mini; T.Mazzei (2005). Aminoglucosidi. In: F.Rossi, V.Cuomo, C.Riccardi. Farmacologia: principi di base e applicazioni terapeutiche., pp. 589-599, torino: Edizioni Minerva Medica., ISBN:9788877114976.

E. Mini; S. Nobili; T. Mazzei (2005). Farmaci antineoplastici - Antimetaboliti. In: F. Rossi, C. Riccardi, V. Cuomo. Farmacologia - Principi di base e applicazioni tecniche, pp. 691-704, Torino: Edizioni Minerva Medica, ISBN:9788877114976.

F.BARCHIESI;E.SPREGHINI;A.SANTINELLI;A.W.FOTHERGILL;S.FALLANI;E.MANSO;E.PISA;D.GIANNINI;A.NOVELLI;M.I.CASSETTA;T.MAZZEI;M.G.RINALDI;G.SCALISE (2005). Efficacy of caspofungin against Aspergillus terreus.. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 49 (12), pp. 5133-5135, ISSN:0066-4804 DOI

T.Mazzei; A.Novelli; E.Mini; P.Periti (2005). Penicilline, cefalosporine e altre beta-lattamine.. In: F.Rossi, V.Cuomo, C.Riccardi. Farmacologia: principi di base e applicazioni terapeutiche, pp. 563-578, Torino.: Edizioni Minerva Medica., ISBN:9788877114976.

Nobili S; Del Buono S; Mazzocchi V; Filippelli F; Checcacci D; Giglioni B; Mazzei T; Mini E (2004). Bimonthly chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT11), infusional 5-fluorouracil/folinic acid (FU/FA) in patients with metastatic colorectal cancer pretreated with CPT11- or OHP-based CHT. ANNALS OF ONCOLOGY, vol. 15 suppl 2, pp. 65-65, ISSN:0923-7534

Di Fabio F; Mini E; Gentile AL; Nobili S; Angelelli B; Giaquinta S; Rojas Llimpe FL; Pinto C;Mazzei T; Martoni A (2004). Neurotoxicity of oxaliplatin (OXA) in advanced colorectal cancer (ACRC) chemotherapy: evaluation of three consecutive prospective studies. ANNALS OF ONCOLOGY, vol. 15 suppl 2, pp. 58-58, ISSN:0923-7534

Nobili S; Del Buono S; Mazzocchi V; Filippelli F; Giglioni B; Mazzei T; Mini E (2004). Biweekly (BW) chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT11), infusional 5-fluorouracil/folinic acid (FU/FA) in patients (PTS) with metastatic colorectal cancer (MCRC) pretreated with CPT11- or OHP-based CHT.. JOURNAL OF CHEMOTHERAPY, vol. 16 (suppl 1), pp. 213-213, ISSN:1120-009X

P. Periti; T. Mazzei (2004). Clarithromycin: pharmacokinetics and pharmacodynamics. ANTIBIOTICS FOR CLINICIANS, vol. 8, pp. 233-240

Mini E.; Nobili S; Del Buono S; Mazzocchi V; Filippelli F; Giglioni B; Mazzei T (2004). Biweekly (BW) chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT11), infusional 5-fluorouracil/folinic acid (FU/FA) in patients (pts) with metastatic colorectal cancer (MCRC) pretreated with CPT11- or OHP-based CHT. JOURNAL OF CLINICAL ONCOLOGY, vol. 22, pp. 3065-3065, ISSN:0732-183X

Morganti M, Ciantelli M, Giglioni B, Putignano AL, Nobili S, Papi L, Landini I, Napoli C, Valanzano R, Cianchi F, Boddi V, Tonelli F, Cortesini C, Mazzei T, Genuardi M, Mini E (2004). Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients.. CANCER RESEARCH, vol. 67, pp. 866-867, ISSN:1538-7445

T. Mazzei; P. Periti (2004). Pharmacodinamics of b-lactam antibiotics. ANTIBIOTICS FOR CLINICIANS, vol. 8, pp. 249-257

Novelli A; Mini E; Mazzei T. (2004). Pharmacological interactions between antibiotics and other drugs in the treatment of lower respiratory tract infections (chapter 15). In: M. Cazzola, F. Blasi and S. Ewig. Antibiotics and the lung, pp. 229-254 M. Cazzola, F. Blasi and S. Ewig, ISBN:9781904097723.

Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E. (2004). Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients. ANNALS OF ONCOLOGY, vol. 15, pp. 61-61, ISSN:0923-7534

Morganti, M; Ciantelli, M; Giglioni, B; Putignano, Al; Nobili, S; Papi, L; Landini, I; Napoli, C; Valanzano, R; Cianchi, F; Boddi, V; Tonelli, F; Cortesini, C; Mazzei, T; Genuardi, M; Mini, E. (2004). Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients. JOURNAL OF CHEMOTHERAPY, vol. 16 (Suppl. 1), pp. 205-205, ISSN:1973-9478

Mini E; Nobili S; Mazzocchi V; Del Buono S; Scicolone S; Giglioni B; Mazzei T (2003). Biweekly (BW) chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT-11), infusional 5-fluorouracil/folinic acis (FU/FA) in patients (PTS) with metastatic colorectal cancer (MCRC) pretreated with CPT-11- or OHP-based CHT. JOURNAL OF CLINICAL ONCOLOGY, vol. 22, pp. 1503-1503, ISSN:0732-183X

Nobili S; Mazzocchi V; Del Buono S.; Scicolone S; Giglioni B; Mazzei T; Mini E (2003). Biweekly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy. JOURNAL OF CHEMOTHERAPY, vol. 15 (Suppl 1), pp. 69-69, ISSN:1973-9478

A. MARTONI; E. MINI; C. PINTO; AL. GENTILE; S. NOBILI; P. DENTICO; A. MARINO; S. SCICOLONE; B. ANGELELLI; T. MAZZEI (2003). OXALIPLATIN PLUS RALTITREXED IN THE TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL CANCER: A PHASE II STUDY. ANTICANCER RESEARCH, vol. 23, pp. 687-691, ISSN:0250-7005, International Institute of Anticancer Research:John G Delinassios, 1st Km Kapandritiou-Kalamou Road, Kapandriti Attiki 19014 Greece:011 30 2 2950 53389, 011 30 2950 52945, EMAIL: journals@iiar-anticancer.org, INTERNET: http://www.iiar-anticancer.org, Fax: 011 30 2 2950 53389, 011 30 2 2950 52945:

Morganti M; Ciantelli M; Giglioni B; Nobili S.; Papi L.; Landini I.; Napoli C.; Valanzano R.; Cianchi F; Boddi V.; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E (2003). Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT). JOURNAL OF TUMOR MARKER ONCOLOGY, vol. 18, pp. 171-171, ISSN:0886-3849

Landini I; Carotti S; Caciagli B; Morganti M; Napoli C; Nobili S; Giglioni B; Boddi V; Mazzei T; Mini E (2003). Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines. JOURNAL OF CHEMOTHERAPY, vol. 15 (Suppl 1), pp. 36-36, ISSN:1973-9478

Gentile AL; Pinto C; Mini E; Nobili S; Di Fabio F; Mazzei T; Martoni A (2003). Neurotoxicity in advanced colorectal cancer (ACRC) patients treated with three different oxaliplatin (OXA) regimens. ANNALS OF ONCOLOGY, vol. 14, pp. 49-49, ISSN:0923-7534

Mazzei T.; Carotti S.; Landini I.; Caciagli B.; Nobili S.; Mini E (2002). Sequence-dependent interactions between oxaliplatin (OHP) and 5-fluorouracil (5-FU) in human colon carcinoma cell lines. JOURNAL OF CLINICAL ONCOLOGY, vol. 21, pp. 2183-2183, ISSN:0732-183X

Martoni A.; Mini E.; Pinto C.; Gentile AL; Nobili S; Marino A; Dentico P; Angelelli B; Scicolone S; Piana E; Mazzei T (2002). Phase II study of oxaliplatin (OHP) and raltitrexed (RTX) in chemonaive and pretreated advanced colorectal cancer (ACRC) patients. JOURNAL OF CLINICAL ONCOLOGY, vol. 21, pp. 689-689, ISSN:0732-183X

F. TONELLI; MAZZEI T; NOVELLI A; MAZZONI P; FICARI F. (2002). Amoxicillin/clavulanic acid versus cefotaxime for antimicrobial prophylaxis in abdominal surgery: a randomized trial.. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 14, pp. 366-372, ISSN:0305-7453, Oxford University Press:Journals Department, Great Clarendon Street, Oxford OX2 6DP United Kingdom:011 44 1865 556767, EMAIL: jnlorders@oup.co.uk, INTERNET: http://www.oup.co.uk, Fax: 011 44 1865 267485:

MARCON G.; CAROTTI S.; CORONNELLO M.; L. MESSORI; MINI E.; ORIOLI P.; MAZZEI T.; CINELLU M.A.; MINGHETTI G. (2002). Gold(III) Complexes with Bipyridyl Ligands: Solution Chemistry, Cytotoxicity and DNA Binding Properties. JOURNAL OF MEDICINAL CHEMISTRY, vol. 45, pp. 1672-1677, ISSN:0022-2623, American Chemical Society:1155 Sixteenth Street Northwest:Washington, DC 20036:(800)227-5558, EMAIL: service@acs.org, INTERNET: http://www.pubs.acs.org, Fax: (614)447-3671:

Mini E, Caciagli B, Carotti S, Landini I, Morganti M, Nobili S, Coronnello M, Toffoli G, Jansen G, Peters GJ, Priest DG, Mazzei T (2002). Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1. In: 93rd Annual Meeting American Association for Cancer Research (AACR), San Francisco, CA, USA, April 6-10, 2002., Waverly Press, pp. 3864-3864.

P. Periti; T. Mazzei; E Mini (2002). Clinical pharmacokinetics of depot leuprorelin.. CLINICAL PHARMACOKINETICS, vol. 41, pp. 485-504, ISSN:0312-5963 Accesso ONLINE all'editore

Mini E.; Morganti M.; Napoli C.; Valanzano R.; Cianchi F.; Messerini A; Nobili S; Boddi V; Tonelli F; Cortesini C; Toffoli G; Mazzei T (2002). The role of thymidylate synthase (TS) expression in prognosis and outcome of 5-fluorouracil (5-FU)-based chemotherapy in patients (pts) with colorectal cancer (CC). JOURNAL OF CLINICAL ONCOLOGY, vol. 21, pp. 2266-2266, ISSN:0732-183X

A. NOVELLI;S.FALLANI;M.I.CASSETTA;S.ARRIGUCCI;T.MAZZEI (2002). In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin.. JOURNAL OF CHEMOTHERAPY, vol. 14 (6), pp. 584-590, ISSN:1120-009X, ESIFT Srl:Casella Postale 147, I 50018 Scandicci Fi Italy:011 39 055 4271516, EMAIL: mary@jchemother.it, Fax: 011 39 055 4271280:

A. Martoni; E. Mini; C. Pinto; A. Gentile; T. Mazzei (2001). [Oxaliplatin: combinations with thymidylate synthetase inhibitors: two consecutive phase II studies]. TUMORI, vol. 87, pp. A25-A26, ISSN:0300-8916

Mini E.; Pinto C.; Gentile A.L.; Marino A.; Angelelli B.; Piana E.; Martoni A.; Nobili S.; Dentico P.; Scicolone S.; Mazzei T (2001). Oxaliplatin (OHP) and raltitrexed (RTX) in advanced colorectal cancer (ACRC) patients (PTS): preliminary results of a phase II study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 17, pp. S21-S21, ISSN:0924-8579

Giordana Marcon; Stefania carotti; Marcella Coronnello; Enrico Mini; Teresita Mazzei; Luigi Messori; Pierluigi Orioli (2001). Gold(III) complexes as potential antitumor agents: cytotoxic properties and interaction with DNA of some selected gold(III) compounds. ANTICANCER RESEARCH, vol. 21, pp. 1601-1601, ISSN:0250-7005

Mini E.; Caciagli B.; Carotti S.; Landini I.; Morganti M.; Nobili S.; Mazzei T.; Toffoli G.; Jansen G.; Peters G.J.; Priest D.J (2001). Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1.. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 17, pp. S20-S20, ISSN:0924-8579

Pinto C.; Mini E.; Gentile A.L.; Nobili S.; Marino A.; Dentico P.; Angelelli B.; Scicolone S.; Piana E.; Iovi F.; Mazzei T.; Martoni A (2001). Oxaliplatin (OHP) and raltitrexed (RTX) in advanced colorectal cancer (ACRC) patients: a phase II study. JOURNAL OF CLINICAL ONCOLOGY, vol. 20, pp. 2204-2204, ISSN:0732-183X

A. Martoni; E. Mini; C. Pinto; S. Nobili; A. L. Gentile; P. Dentico; B. Angelelli; S. Scicolone; E. Piana; T. Mazzei (2001). Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma.. ANNALS OF ONCOLOGY, vol. 12, pp. 519-524, ISSN:0923-7534 Accesso ONLINE all'editore

M. Coronnello; G. Marcon; S. Carotti; B. Caciagli; E. Mini; T. Mazzei; P. Orioli; L. Messori (2001). Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivity. ONCOLOGY RESEARCH, vol. 12, pp. 361-370, ISSN:0965-0407

Mini E.; Caciagli B.; Carotti S.; Landini I.; Morganti M.; Nobili S.; Coronnello M.; Toffoli G.; Jansen G.; Peters G.J.; Priest D.G.; Mazzei T (2001). Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1. PHARMACOLOGICAL RESEARCH, vol. 43 suppl A, pp. 133-133, ISSN:1043-6618

Carotti S.; Landini I.; Caciagli B.; Nobili S.; Mazzei T.; Mini E (2001). Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines. ANNALS OF ONCOLOGY, vol. 12 suppl 4, pp. 86-86, ISSN:0923-7534

Pinto C.; Mini E.; Gentile A.L.; Marino A.; Nobili S.; Dentico P.; Angelelli B.; Carpani B.; Scicolone S.; Mazzei T.; Martoni A (2001). Neurotoxicity in patients treated with oxaliplatin (OHP) combination chemotherapy for advanced colorectal cancer (ACRC) in two consecutive phase II studies. ANNALS OF ONCOLOGY, vol. 12 suppl 4, pp. 8-8, ISSN:0923-7534

M.CIPOLLI;G.CAZZOLA;A.NOVELLI;M.I.CASSETTA;S.FALLANI;T.MAZZEI (2001). Azithromycin concentrations in serum and bronchial secretions of patients with cystic fibrosis. CLINICAL DRUG INVESTIGATION, vol. 21, pp. 353-360, ISSN:1173-2563

D.Passàli;T.Mazzei;A.Novelli; S.Fallani; P.Dentico;C.Mezzedimi;G.C.Passàli;L.Bellussi (2001). Amoxicillin/clavulanate in chronic rhinosinusitis: tissue and serum distribution.. ACTA OTO-RHINO-LARYNGOLOGICA BELGICA, vol. 55, pp. 259-264, ISSN:0001-6497

L. Messori; F. Abbate; G. Marcon; P. Orioli; M. Fontani; E. Mini; T. Mazzei; S. Carotti; T. O'Connell; P. Zanello (2000). Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds.. JOURNAL OF MEDICINAL CHEMISTRY, vol. 43, pp. 3541-3548, ISSN:0022-2623

T. MAZZEI; DENTICO P (2000). The pharmacokinetics of oral cephalosporins.. CLINICAL MICROBIOLOGY AND INFECTION, vol. 6 Suppl 3, pp. 53-54, ISSN:1198-743X

Napoli C.; Morganti P.; Bruno L.; Nobili S.; Cortesini C.; Mazzei T.; Mini E (2000). Preliminary results of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression analysis by polymerase chain reaction (PCR) in gastric cancer patients (PTS). ANNALS OF ONCOLOGY, vol. 11, pp. 16-16, ISSN:0923-7534

S. CAROTTI; G. MARCON; M. MARUSSICH; T. MAZZEI; L. MESSORI; E. MINI; P. ORIOLI (2000). Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold(III) complex (GHAu).. CHEMICO-BIOLOGICAL INTERACTIONS, vol. 125, pp. 29-38, ISSN:0009-2797

Napoli C.; Morganti M.; Bruno L.; Nobili S.; Cortesini C.; Mazzei T.; Mini E (2000). Expression of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) genes by polymerase chain reaction (PCR) in gastric cancer patients (PTS): preliminary results. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, pp. 249-249, ISSN:0306-5251

T.MAZZEI;A.NOVELLI;S.ESPOSITO;S.FALLANI;S.NOVIELLO;M.I.CASSETTA;S.CONTI;P.PERITI (2000). Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients.. JOURNAL OF CHEMOTHERAPY, vol. 12 (4), pp. 306-313, ISSN:1120-009X, ESIFT Srl:Casella Postale 147, I 50018 Scandicci Fi Italy:011 39 055 4271516, EMAIL: mary@jchemother.it, Fax: 011 39 055 4271280:

M. Morganti; M. Coronnello; B. Caciagli; C. Biondi; A. Quattrone; S. Capaccioli; T. Mazzei; E. Mini (2000). Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides.. ANTI-CANCER DRUGS, vol. 11, pp. 285-294, ISSN:0959-4973 Accesso ONLINE all'editore

Pinto C; Mini E; Petronelli A; Dentico P; Piana E; Nobili S; Gentile A; Scicolone S; Mazzei T; Martoni A (2000). Oxaliplatin (OHP) and Protracted 5-Fluorouracil (5 FU) Infusion in Pretreated Metastatic Colorectal Cancer (MCRC) Patients: A Phase II Study. JOURNAL OF CLINICAL ONCOLOGY, vol. 19, pp. 1172-1172, ISSN:0732-183X

T.MAZZEI;A. NOVELLI;S.ESPOSITO;P.PERITI (2000). New Insight into the Clinical Pharmacokinetics of Cefaclor: Tissue Penetration.. JOURNAL OF CHEMOTHERAPY, vol. 12, pp. 53-62, ISSN:1120-009X, ESIFT Srl:Casella Postale 147, I 50018 Scandicci Fi Italy:011 39 055 4271516, EMAIL: mary@jchemother.it, Fax: 011 39 055 4271280:

BARCHIESI F; SCHIMIZZI AM; CASELLI F; NOVELLI A; FALLANI S; GIANNINI D; ARZENI D; DI CESARE S; DI FRANCESCO LF; FORTUNA M; GIACOMETTI A; CARLE F; MAZZEI T; SCALISE G. (2000). Interactions between triazoles and amphotericin B against Cryptococcus neoformans.. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 44 (9), pp. 2435-2441, ISSN:0066-4804

Mini E.; Pinto C.; Angelelli B.; Dentico P.; Piana E.; Nobili S.; Gentile A.L.; Scicolone S.; Mazzei T.; Martoni A (2000). Phase II study of oxaliplatin (OHP) and protracted 5-fluorouracil (5FU) infusion in pretreated metastatic colorectal cancer (MCRC) patients. ANNALS OF ONCOLOGY, vol. 11 suppl 2, pp. 73-73, ISSN:0923-7534

A. NOVELLI; FALLANI S; CASSETTA M.I; CONTI S; MAZZEI T. (2000). Postantibiotic leukocyte enhancement of meropenem against Gram-positive and Gram-negative strains. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 44 (11), pp. 3174-3176, ISSN:0066-4804

Messori L.; Caciagli B.; Carotti S.; Coronnello M.; Marcon G.; Mazzei T.; Mini E (2000). Solution chemistry and DNA binding properties of cytotoxic gold(III) complexes.. JOURNAL OF CHEMOTHERAPY, pp. 139-139, ISSN:1120-009X

P. Periti; T. Mazzei (1999). New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock.. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 12, pp. 97-105, ISSN:0924-8579

E. Mini; P. Pinzani; G. Amunni; A. Villanucci; T. Mazzei; M. Pazzagli (1999). Correlation of in vitro drug sensitivity and clinical response in ovarian carcinoma using an ATP-luminescence tumor chemosensitivity assay. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 44 (Suppl A), pp. 160-160, ISSN:0305-7453

Mini E; Biondi C; Morganti M; Napoli C; Mazzoni P; Cianchi F; Tonelli F; Cortesini C; Capaccioli S; Ficari F; Quattrone A; Rossi S; Mazzei T. (1999). Marked variation of thymidylate synthase and folylpolyglutamate synthetase gene expression in human colorectal tumors.. ONCOLOGY RESEARCH, vol. 11, pp. 437-445, ISSN:0965-0407

Caciagli B.; Carotti S.; Morganti M.; Landini I.; Nobili S.; Mazzei T.; Toffoli G.; Mini E (1999). Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 44, pp. 162-162, ISSN:0305-7453

E Mini , C Biondi, M Morganti, C Napoli, P Mazzoni, F Cianchi, F Tonelli, C Cortesini, S Capaccioli, F Ficari, A Quattrone, S Rossi, T Mazzei (1999). Marked variation of thymidylate synthase and folylpolyglutamate synthetase gene expression in human colorectal tumors.. ONCOLOGY RESEARCH, vol. 11, pp. 437-445, ISSN:1555-3906

MAZZEI T; SURRENTI C; A. NOVELLI; BIAGINI M.R; FALLANI S; CASSETTA M.I; CONTI S; SURRENTI E (1999). Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 43, pp. 1556-1559, ISSN:0066-4804

P. Periti; T. Mazzei (1999). Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen.. JOURNAL OF CHEMOTHERAPY, vol. 11, pp. 11-27, ISSN:1120-009X

Morganti M.; Coronnello M.; Napoli C.; Quattrone A.; Mazzei T.; Capaccioli S.; Mini E (1999). Modulation of fluorodeoxyuridine cytotoxicity in human adenocarcinoma HCT-8 cells by antisense oligonucleotides targeted to thymidylate synthase.. PHARMACOLOGICAL RESEARCH, vol. 39, pp. 99-99, ISSN:1043-6618

Mini E; Mazzei T; Nobili S; Periti P (1999). High-dose intravenous quinolones: efficacy and safety in lower respiratory tract infection therapy. JOURNAL OF CHEMOTHERAPY, vol. 11 (Suppl 2), pp. 52-52, ISSN:1973-9478

Morganti M.; Coronnello M.; Napoli C.; Quattrone A.; Mazzei T.; Capaccioli S.; Mini E (1999). Modulation of fluorodeoxyuridine cytotoxicity in human adenocarcinoma HCT-8 cells by antisense oligonucleotides targeted to thymidylate synthase.. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, pp. 161-161, ISSN:0305-7453

Caciagli B.; Carotti S.; Morganti M.; Landini I.; Nobili S.; Mazzei T.; Toffoli G.; Mini E (1999). Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1. PHARMACOLOGICAL RESEARCH, vol. 39, pp. 99-99, ISSN:1043-6618

Mini E, Biondi C, Morganti M, Napoli C, Mazzoni P, Cianchi F, Rossi S, Tonelli F, Cortesini C, Mazzei T (1998). Marked variation thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer. In: 34th Annual Meeting of the American Society of Clinical Oncology, Los Angeles, CA, USA, Maggio 16-19, 1998, American Society of Clinical Oncology, pp. 298-298.

P. Calamai; S. Carotti; A. Guerri; T. Mazzei; L. Messori; E. Mini; P. Orioli; G.P. Speroni (1998). Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.. ANTI-CANCER DRUG DESIGN, vol. 13, pp. 67-80, ISSN:0266-9536

Biondi C; Morganti M; Napoli C; Mazzoni P; Cianchi F; Rossi S; Tonelli F; Cortesini C; Mazzei T; Mini E. (1998). Quantitation of intratumoral thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression by the Polymerae Chain Reaction (PCR): marked variation among human colorectal cancer patients.. In: 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, Giugno 16-19, pp. 162-162.

Mini E.; Biondi C; Morganti M; Napoli C; Mazzoni P; Cianchi F; Rossi S; Tonelli F; Cortesini C; Mazzei T. (1998). Marked variation in thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer.. In: Proceedings of the American Society of Clinical Oncology, Los Angeles, Maggio 16-19, vol. 17, pp. 298-298.

Biondi C; Morganti M; Napoli C; Mazzoni P; Cianchi F; Rossi S; Tonelli F; Cortesini C; Mazzei T; Mini E. (1998). Quantitation of intratumoral thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression by the polymerae chain reaction (PCR): marked variation among human colorectal cancer patients.. In: 6th Joint Meeting of the Italian, Hungarian and Polish Pharmacological Societies, Pisa, 14-16 Maggio, pp. 35-35.

P. Periti; T. Mazzei (1998). Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review.. JOURNAL OF CHEMOTHERAPY, vol. 10, pp. 427-448, ISSN:1120-009X

Carotti S, Guerri A, Mazzei T, Messori L, Mini E, Orioli P (1998). Gold(III) compounds as potential antitumor agents: cytotoxicity and DNA binding of some selected gold(III) complexes. In: 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, The Netherlands, Giugno 16-19, 1998, -, pp. 29-29.

Mazzei T.; Bellacci A.; Pesciullesi A.; Galli A.; Carlà V.; Nobili S.; Caciagli B.; Pace M.; Mini E (1998). Pharmacokinetic monitoring of melphalan (L-PAM) during hyperthermic perfusion in patients (PTS) with melanoma of the limbs. JOURNAL OF CLINICAL ONCOLOGY, vol. 17, pp. 228-228, ISSN:0732-183X

Calamai, P; Carotti, S; Guerri, A; Mazzei, T; Messori, L; Mini, E; Orioli, P; Speroni, G P (1998). Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin. ANTI-CANCER DRUG DESIGN, vol. 13, pp. 67-80, ISSN:0266-9536

P. Borri; M. Coronnello; I. Noci; A. Pesciullesi; A. Peri; R. Caligiani; M. Maggi; F. Torricelli; G. Scarselli; O. Chieffi; T. Mazzei; E. Mini (1998). Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues.. GYNECOLOGIC ONCOLOGY, vol. 71, pp. 396-403, ISSN:0090-8258

P. Periti; T. Mazzei; M. E. Curti (1998). Efficacy and safety of high dose intravenous ciprofloxacin in the treatment of bacterial pneumonia. Italian Ciprofloxacin Study Group.. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 10, pp. 215-222, ISSN:0924-8579

Biondi C, Morganti M, Napoli C, Mazzoni P, Cianchi F, Rossi S, Tonelli F, Cortesini C, Mazzei T, Mini E (1998). Quantitation of intratumoral thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression by the Polymerase Chain Reaction (PCR): marked variation among human colorectal cancer patients. In: 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, The Netherlands, Giugno 16-19, 1998, -, pp. 162-162.

Pesciullesi A.; Bellacci A.; Carla V.; Galli A.; Nobili S.; Mini E.; Pace M.; Mazzei T. (1997). Pharmacokinetics of melphalan (L-PAM) during hyperthermic perfusion in patients with melanoma of the limbs. PHARMACOLOGICAL RESEARCH, vol. 35, pp. 232-233, ISSN:1043-6618

Biondi C.; Morganti M.; Carotti S.; Pesciullesi A.; Caciagli B.; Mini E.; Mazzei T. (1997). Quantitative analysis by polymerase chain reaction (PCR) of genes involved in resistance to cytotoxic antimetabolites. PHARMACOLOGICAL RESEARCH, vol. 35, pp. 233-234, ISSN:1043-6618

P. Pinzani; S. Carotti; A. Gerli; M. Pazzagli; T. Mazzei; E. Mini (1997). Evaluation of methotrexate sensitivity in human leukemia cell lines by an adenosine triphosphate bioluminescence assay. ANTI-CANCER DRUGS, vol. 8, pp. 767-777, ISSN:0959-4973

Pesciullesi A.; Bellacci A.; Carlà V.; Galli A.; Nobili S.; Mini E.; Pace M.; Mazzei T (1997). Pharmacokinetic monitoring of melphalan (L-PAM) during hyperthermic perfusion in patients with melanoma of the limbs. PHARMACOLOGICAL RESEARCH, vol. 35, pp. 232-233, ISSN:1043-6618

Biondi C.; Morganti M.; Napoli C.; Mazzoni P.; Cianchi F.; Rossi S.; Tonelli F.; Cortesini C.; Mazzei T.; Mini E (1997). Marked variation of thymidylate synthase and folylpolyglutamate synthetase gene expression in human colorectal cancer.. In: Biomedicina ’97 – Meeting on Moleculare Medicine, Firenze, 26-28 Novembre, pp. 48-48.

Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Mazzoni P (1996). A randomized multicenter study comparing 5-fluorouracil (5-FU) and l-folinic acid (L-LV) alone or with levamisole (LEV) or interferon alpha2a (IFNalpha2a) as adjuvant therapy for colorectal cancer. In: Thirty-Second Annual Meeting of the American Society of Clinical Oncology, Philadelphia, PA, USA, Maggio 18-21, 1986, American Society of Clinical Oncology, pp. 226-226.

A.NOVELLI;T.MAZZEI;E.MELI;S.CONTI;S.FALLANI;P.PERITI (1996). Clinical pharmacokinetics of meropenem after the first and tenth intramuscular administration.. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 37 (4), pp. 775-781, ISSN:0305-7453, ESIFT Srl:Casella Postale 147, I 50018 Scandicci Fi Italy:011 39 055 4271516, EMAIL: mary@jchemother.it, Fax: 011 39 055 4271280:

Morganti M.; Caciagli B.; Coronnello M.; Quattrone A.; Capaccioli S.; Mazzei T.; Mini E. (1996). Modulation of dihydrofolate reductase (DHFR) mRNA levels in human leukemia CCRF-CEM/E line overexpressing this enzyme by antisense oligodeoxynucleotides.. TUMORI, vol. 82/suppl.4, pp. 26-26, ISSN:0300-8916

A. Valeri; E. Mini; P. Tonelli; I. Agostino; B. Neri; S. Nobili; D. Borrelli; T. Mazzei (1996). Treatment of unresecable liver metastases from colorectal carcinoma with hepatic arterial and systemic chemotherapy. JOURNAL OF CHEMOTHERAPY, vol. 8(4), pp. 216-218, ISSN:1120-009X

T. Mazzei; E. Mini; P. Mazzoni; F. Ficari; P. Periti; F. Tonelli; and other participants of the Gruppo Oncologico-Chirurgico Cooperativo Italiano (GOCCI) (1996). Adjuvant therapy of colorectal carcinoma with 5-fluorouracil and l-folinic acid alone or combined with levamisole or interferon-alfa2a. Preliminary toxicological results of a multicenter study of the Italian Cooperative Oncological-Surgical Group (GOCCI). JOURNAL OF CHEMOTHERAPY, vol. 8 (Suppl 4), pp. 147-151, ISSN:1120-009X

Morganti M.; Caciagli B.; Coronnello M.; Carotti S.; Biondi C.; Quattrone A.; Capaccioli S.; Mazzei T.; Mini E. (1996). Modulazione dei livelli di mRNA della diidrofolico reduttasi mediante oligonucleotidi antisenso in cellule leucemiche umane (CCRF-CEM/E) con superespressione di questo enzima.. JOURNAL OF CHEMOTHERAPY, vol. 8/suppl.3, pp. 73-73, ISSN:1120-009X

Mini E, Pazzagli M, Pinzani P, Carotti S, Gerli A, Mazzei T (1995). Evaluation of methotrexate (MTX) sensitivity by an ATP bioluminescence assay in human leukemia cells. THE CANADIAN JOURNAL OF INFECTIOUS DISEASES, vol. 6, pp. 476-476, ISSN:1180-2332

Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Mazzoni P (1995). Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or with levamisole (LEV) or interferon alpha2a (IFN alpha2a).. THE CANADIAN JOURNAL OF INFECTIOUS DISEASES, vol. 6, pp. 209-209, ISSN:1180-2332

T. Mazzei; F. Tonelli; E. Mini; P. Mazzoni; A. Pesciullesi; R. Valanzano; F. Ficari; C. Biondi; P. Periti (1995). Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.. ANTICANCER RESEARCH, vol. 15, pp. 2247-2253, ISSN:0250-7005

Periti P, Rizzo M, Mazzei T, Mini E (1995). Depot leuprorelin acetate alone or with nilutamide in the treatment of metastatic prostate carcinoma: interim report of a multicenter, double-blind, placebo-controlled study. THE CANADIAN JOURNAL OF INFECTIOUS DISEASES, vol. 6, pp. 293-293, ISSN:1180-2332

A.NOVELLI;T.MAZZEI;S.FALLANI;R.DEI;M.I.CASSETTA;S.CONTI (1995). Betalactam therapy and intestinal flora.. JOURNAL OF CHEMOTHERAPY, vol. 7 (suppl 1), pp. 25-31, ISSN:1120-009X, ESIFT Srl:Casella Postale 147, I 50018 Scandicci Fi Italy:011 39 055 4271516, EMAIL: mary@jchemother.it, Fax: 011 39 055 4271280:

T.Mazzei;A.Novelli;F.De Lalla;E. Mini;P. Periti (1995). Tissue penetration and pulmonary disposition of tobramycin.. JOURNAL OF CHEMOTHERAPY, vol. 7, pp. 363-370, ISSN:1120-009X

Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Mazzoni P, Dentico P (1995). Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a Multicenter Study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano.. In: 15th Anniversary International Congress. Colorectal cancer: from Gene to Cure, Amsterdam, The Netherlands, Febbraio 9-11, 1995, -, pp. 51-51.

Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Mazzoni P (1995). Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a multicenter study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano (GOCCI). In: 31st Annual Meeting of the American Society of Clinical Oncology, Los Angeles, CA, USA, Maggio 20-23, 1995, American Society of Clinical Oncology, pp. 219-219.

Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Nobili S, Mazzoni P (1995). Adjuvant chemotherapy with 5-fluorouracil (5-FU) and folinic acid (L-LV) for colorectal carcinoma: preliminary results of a randomized multicenter study of the Gruppo Cooperativo Oncologico Tosco-Umbro (GCOTU). In: 15th Anniversary International Congress. Colorectal cancer: from Gene to Cure, Amsterdam, The Netherlands, Febraio 9-11, 1995, -, pp. 49-49.

Bellacci A, Pesciullesi A, Galli A, Carlà V, Mini E, Mazzei T, Pace M (1995). Pharmacokinetics of melphalan n (L-PAM) in true and mild hyperthermic perfusion in patients with melanoma of the lower limb. A preliminary report. In: 5th International Congress on Anti-Cancer Chemotherapy (Neo-Adjuvant, Adjuvant and Experimental), Paris, France, Gennaio 31-1 Febbraio, 1995, -, pp. 126-126.

I. A. Cree; M. Pazzagli; E. Mini; T. Mazzei; E. M. Hunter; L. A. Sutherland; P. Pinzani; A. Gerli; P. E. Andreotti (1995). Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay.. ANTI-CANCER DRUGS, vol. 6, pp. 398-404, ISSN:0959-4973

A.NOVELLI;T.MAZZEI;S.FALLANI;M.I.CASSETTA;S.CONTI (1995). In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin.. JOURNAL OF CHEMOTHERAPY, vol. 7 (4), pp. 355-362, ISSN:1120-009X, ESIFT Srl:Casella Postale 147, I 50018 Scandicci Fi Italy:011 39 055 4271516, EMAIL: mary@jchemother.it, Fax: 011 39 055 4271280:

MAZZEI T; TONELLI F; A. NOVELLI; FICARI F; MAZZONI C; ANASTASI A; PERITI P. (1994). Penetration of cefotetan into suction skin blister fluid and tissue homogenates in patients undergoing abdominal surgery.. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 38, pp. 2221-2223, ISSN:0066-4804

Mini E, Mazzei T, Carotti S, Coronnello M, Gerli A, Pesciullesi A, Periti P (1994). Effect of the l and d stereoisomers of 5-formyltetrahydrofolate (LV) and 5-methytetrahydrofolate (5-CH3-H4PteGlu) on fluoropyrimidine cytotoxicity in human leukemic CCRF-CEM cells. In: 18th International Congress of Chemotherapy, Stockholm, Sweden, Giugno 27 – Luglio 2, 1993, -, pp. 1164-1164.

Mini E, Mazzei T, Periti P (1994). Mechanisms of resistance to methotrexate (MTX) in human tumors and pharmacological strategies for its circumvention. In: 9th Mediterranean Congress of Chemotherapy, Milan, Italy, Giugno 12-17, 1994, -, pp. 19-19.

ROSSO R.; MAZZEI T.; SOBRERO A.; E. MINI; CARTEI G.; CONTE P.; LA BIANCA R.; CARTEI F.; FALCONE A.; PANCERA G.; BARSANTI G.; DI COSTANZO F; GUGLIELMI A.; BOLLI E.; TIXI L.; ASCHELE C.; RIBECCO A.; PERITI P. (1994). PHASE II TRIAL OF 5-FLUOROURACIL AND THE NATURAL L-ISOMER OF FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL CARCINOMA.. EUROPEAN JOURNAL OF CANCER, vol. 30A(3), pp. 338-343, ISSN:0959-8049, Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: asianfo@elsevier.com, tcb@elsevier.co.UK, INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010:

A. Quattrone; L. Papucci; M. Morganti; M. Coronnello; E. Mini; T. Mazzei; F.P. Colonna; A. Garbesi; S. Capaccioli (1994). Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance. ONCOLOGY RESEARCH, vol. 6, pp. 311-320, ISSN:0965-0407

Periti P, Stringa G, Mazzei T, Mini E, Dentico P (1994). Antimicrobial prophylaxis in prosthetic joint implant surgery: a comparative multicenter trial between teicoplanin and cefazolin. In: 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Orlando, FL, USA, Ottobre 4-8, 1994, -, pp. 5-5.

A. Valeri; E. Mini; P. Tonelli; F. Veneri; B. Neri; D. Borrelli; T. Mazzei (1994). Intra-arterial chemotherapy with 5-fluorouracil and 5-methyltetrahydrofolate in the treatment of unresectable liver metastases from colorectal cancer. ANTICANCER RESEARCH, vol. 14, pp. 2215-2220, ISSN:0250-7005

A. NOVELLI; MAZZEI T; MELI E; CASSETTA M.I; FALLANI S; PERITI P. (1993). Pharmacokinetics and blister fluid penetration of brodimoprim in adults.. JOURNAL OF CHEMOTHERAPY, vol. 5 (6), pp. 494-498, ISSN:1120-009X, ESIFT Srl:Casella Postale 147, I 50018 Scandicci Fi Italy:011 39 055 4271516, EMAIL: mary@jchemother.it, Fax: 011 39 055 4271280:

Periti P, Stringa G, Mazzei T, Mini E, Novelli A, Calviani L (1993). A comparison of the prophylactic use of teicoplanin or cefazolin in the prevention of infections complications of hip and knee prosthesis insertion. In: 18th International Congress of Chemotherapy, Stockholm, Sweden, Giugno 27 – Luglio 2, 1993, -, pp. 1442-1442.

P. Periti; T. Mazzei; E. Mini; A. Novelli (1993). Adverse effects of macrolide antibacterials.. DRUG SAFETY, vol. 9, pp. 346-364, ISSN:0114-5916

T.Mazzei;C.Surrenti;A.Novelli;A.Crispo;S.Fallani;V.Carlà;E.Surrenti;P. Periti (1993). Pharmacokinetics of azithromycin in patients with impaired hepatic function.. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 31 Suppl E, pp. 57-63, ISSN:0305-7453

Novelli A, Mazzei T, Mini E, Cassetta MI, Fallani S, Periti P (1993). Pharmacokinetics and blister fluid penetration of ticarcillin/clavulanate in adults. In: 18th International Congress of Chemotherapy, Stockholm, Sweden, Giugno 27 – Luglio 2, 1993, -, pp. 817-817.

Mini E.; Carotti S.; Gerli A.; Coronnello M.; Pe¬sciullesi A.; Morganti M.; Biondi C.; Ghione M.; Mazzei T. (1993). Valutazione dell'indice terapeu¬tico in vi¬tro di un vettore liposomiale veicolante metotrexato (MTX) in cellule leucemiche umane CCRF-CEM in immu¬nociti umani nor¬mali.. TUMORI, vol. 79/suppl.3, pp. 141-141, ISSN:0300-8916

A. Novelli; T. Mazzei; P. Periti (1993). Diffusione del brodimoprim nel liquido della bolla cutanea da suzione nell'uomo. JOURNAL OF CHEMOTHERAPY, vol. 5 (Suppl 2), pp. 21-26, ISSN:1120-009X

S. Capaccioli; G. Di Pasquale; E. Mini; T. Mazzei; A. Quattrone (1993). Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 197, pp. 818-825, ISSN:0006-291X

T. Bergan; A. Stockis; S. Kaftezis; H. Schmid; F. Scaglione; M. Maciocchi; E. Wiedekamm; G. Villa; S. Reggio; E. Mini; T. Mazzei; F. Paradisi (1993). Clinical pharmacology. Discussion. JOURNAL OF CHEMOTHERAPY, vol. 5, pp. 502-503, ISSN:1120-009X

P. Periti; F. Tonelli; T. Mazzei; F. Ficari (1993). Antimicrobial chemoimmunoprophylaxis in colorectal surgery with cefotetan and thymostimulin: prospective, controlled multicenter study. Italian Study Group on Antimicrobial Prophylaxis in Abdominal Surgery.. JOURNAL OF CHEMOTHERAPY, vol. 5, pp. 37-42, ISSN:1120-009X

Coronnello M.; Pesciullesi A.; Carotti S.; Gerli A.; Morganti M.; Biondi C.; Mini E.; Mazzei T (1993). Flow cy¬tometric evaluation of the in¬hibitory effects of li¬posome-entrapped methotrexate (MTX) on lymphocyte proliferation and polymorphonuclear (PMN) leukocyte functions.. EUROPEAN JOURNAL OF HISTOCHEMISTRY, vol. 37/suppl.2, pp. 84-84, ISSN:1121-760X

T.Mazzei;E.Mini;A.Novelli;P.Periti (1993). Chemistry and mode of action of macrolides.. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 31 Suppl C, pp. 1-9, ISSN:0305-7453

Mazzei, T; Novelli, A; Mini, E; Periti, P (1992). [Plasma and tissue antibiotic concentrations: what is their prognostic value?]. ANNALI ITALIANI DI MEDICINA INTERNA, vol. 7, pp. 67s-73s, ISSN:0393-9340

P.PERITI;T.MAZZEI;E.MINI;A.NOVELLI (1992). Pharmacokinetic drug interaction of macrolides. CLINICAL PHARMACOKINETICS, vol. 23, pp. 106-131, ISSN:0312-5963

P.Periti;G.Stringa;L.Donati;T.Mazzei;E.Mini;A.Novelli (1992). Teicoplanin--its role as systemic therapy of burn infections and as prophylaxis for orthopaedic surgery. Italian Study Groups for Antimicrobial Prophylaxis in Orthopaedic Surgery and Burns.. EUROPEAN JOURNAL OF SURGERY, vol. S 567, pp. 3-8, ISSN:1102-4151

Mini E, Mazzei T, Ribecco A, Periti P (1991). Phase I study of LY186641 given on alternative weeks to patients (pts) with solid tumors. In: 27th Annual Meeting of the American Society of Clinical Oncology, Houston, TX, USA, Maggio 19-21, 1991, American Society of Clinical Oncology, pp. 110-110.

P. Periti; T. Mazzei; A. Novelli; M. Rizzo; and other partecipants in the Italian Cooperative Study Group (1991). Efficacy and safety of once-daily versus twice-daily administration of netilmicin in patients with urinary tract infections. JOURNAL OF CHEMOTHERAPY, vol. 3, pp. 369-371, ISSN:1120-009X

A.NOVELLI;T.MAZZEI;S.FALLANI;M.I.CASSETTA;E.PERITI;P.PERITI (1991). Clinical pharmacokinetics and tissue penetration of netilmicin given once versus twice daily.. In: 7° Mediterranean Congress of Chemotherapy, pp. 229-232.

Periti P, Novelli A, Mini E, Mazzei T, Cassetta MI (1991). Clinical pharmacokinetics of cefpodoxime proxetil in older patients. In: 17th International Congress of Chemotherapy, Berlin, Federal Republic of Germany, Giugno 23-28, 1991, -, pp. 250-250.

Periti P, Novelli A, Mazzei T, Mini E, Fallani S (1991). Comparative in vitro activity of ciprofloxacin against methicillin-resistant staphylococci. In: 17th International Congress of Chemotherapy, Berlin, Federal Republic of Germany, Giugno 23-28, 1991, -, pp. 626-626.

Periti P, Stringa G, Donati L, Mazzei T, Mini E, Novelli A (1991). Teicoplanin: its role as systemic burn therapy and as prophylaxis for orthopedic surgery. In: 17th International Congress of Chemotherapy, Berlin, Federal Republic of Germany, Giugno 23-28, 1991, -, pp. 545-545.

Mini E.; Bernabei P.A.; Gerli A.; Carotti S.; Coronnello M.; Pesciullesi A.; Mazzei T (1991). Citotossicità comparativa di metotrexato (MTX) e trimetrexato (TMTX) in cellule leucemiche umane.. TUMORI, vol. 77/suppl.3, pp. 166-166, ISSN:0300-8916

T.Mazzei;F.Tonelli;A.Anastasi;F.Ficari;A.Novelli;P.Periti (1991). Tissue distribution of cefotetan in patients with Crohn's disease.. CHEMOTHERAPY, vol. 37, pp. 297-302, ISSN:0009-3157

A.Novelli;E.Periti;G.B.Massi;R.Masi;T.Mazzei;P. Periti (1991). Systemic absorption of 3H-fenticonazole after vaginal administration of 1 gram in patients.. JOURNAL OF CHEMOTHERAPY, vol. 3, pp. 23-27, ISSN:1120-009X

E. Mini; R. Stanyon; M. Coronnello; A. Gerli; T. Mazzei; P. Periti (1991). Chromosomal characterization of methotrexate-resistant human T-lymphoblast leukemia cells (CCRF-CEM) with impaired polyglutamylation.. TUMORI, vol. 77, pp. 95-99, ISSN:0300-8916

P.PERITI;T.MAZZEI;A.NOVELLI;M.RIZZO (1991). Efficacy and safety of once-daily versus twice-daily administration of netilmicin in patients with urinary tract infections.. In: 7° Mediterranean Congress of Chemotherapy, pp. 369-371.

P. Periti; F. Pannuti; G. R. Della; T. Mazzei; E. Mini; A. Martoni; P. Preti; L. Ercolino; L. Pavesi; A. Ribecco (1991). Combination chemotherapy with cyclophosphamide, fluorouracil, and either epirubicin or mitoxantrone: a comparative randomized multicenter study in metastatic breast carcinoma.. CANCER INVESTIGATION, vol. 9, pp. 249-255, ISSN:0735-7907

Mini E.; Mazzei T.; Carotti S.; Coronnello M.; Gerli A.; Pesciullesi A.; Periti P (1991). Characterization and selective pharmacologic circumven¬tion of metho¬trexate (MTX) resi¬stance in leukemia cells. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, vol. suppl.2, pp. S11-S11, ISSN:0277-5379

Periti P, Novelli A, Mazzei T, Mini E, Casetta MI (1991). Clinical pharmacokinetics and tissue penetration of cefpirome in the elderly. In: 17th International Congress of Chemotherapy, Berlin, Federal Republic of Germany, Giugno 23-28, 1991, -, pp. 268-268.

Periti P, Mazzei T, Mini E, Ribecco A, Aglietti A (1990). Phase I study of LY186641, a diarylsulfonylurea given on alternative weeks to patients with solid tumours. ANNALS OF ONCOLOGY, vol. 1, pp. 40-40, ISSN:0923-7534

E. Mini; M. Coronnello; S. Carotti; A. Gerli; A. Pesciullesi; B. A. Moroson; T. Mazzei; P. Periti; J. R. Bertino (1990). Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemia.. JOURNAL OF CHEMOTHERAPY, vol. 2 Suppl 1, pp. 17-27, ISSN:1120-009X

M. Rizzo; T. Mazzei; E. Mini; R. Bartoletti; P. Periti (1990). Leuprorelin acetate depot in advanced prostatic cancer: a phase II multicentre trial.. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol. 18 Suppl 1, pp. 114-125, ISSN:0300-0605

T. Mazzei; E. Mini; M. Rizzo; P. Periti (1990). Human pharmacokinetic and pharmacodynamic profiles of leuprorelin acetate depot in prostatic cancer patients.. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, vol. 18 Suppl 1, pp. 42-56, ISSN:0300-0605

T. Mazzei; P. Periti (1989). Tissue distribution of antimicrobial drugs.. JOURNAL OF CHEMOTHERAPY, vol. 1, pp. 75-79, ISSN:1120-009X

E. Mini; A. Novelli; T. Mazzei; P. Periti (1989). Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci.. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, vol. 8, pp. 256-260, ISSN:0934-9723

E.Mini;T.Mazzei;E.F.Reali;A.Novelli;P.Periti (1989). Pharmacokinetics of teicoplanin during cardiopulmonary bypass surgery.. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, vol. 9, pp. 287-292, ISSN:0251-1649

P. Periti; T. Mazzei; E. Mini; A. Novelli (1989). Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part I).. CLINICAL PHARMACOKINETICS, vol. 16, pp. 193-214, ISSN:0312-5963

A.Novelli;T.Mazzei;E.F.Reali;E.Mini;P.Periti (1989). Clinical pharmacokinetics and tissue penetration of teicoplanin.. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, vol. 9, pp. 233-237, ISSN:0251-1649

Mini E.; Coronnello M.; Carotti S.; Pesciullesi A.; Mazzei T.; Periti P (1989). Effetti di esposizioni alter¬nate a trimetressato (TMTX) e metotres¬sato (MTX) sulla insorgenza di resistenza agli antifolici in un modello di leucemia T-linfoblastica umana (CCRF-CEM) in vitro.. TUMORI, vol. 75/suppl.4, pp. 51-51, ISSN:0300-8916

P. A. Bernabei; E. Mini; V. Gattei; F. C. Agostino; R. Bezzini; R. Saccardi; V. Santini; M. Coronnello; T. Mazzei; P. Rossi Ferrini (1989). Induction of differentiation of HL-60 cells along the monocytic pathway by 5-methyltetrahydrofolate.. JOURNAL OF CHEMOTHERAPY, vol. 1, pp. 359-364, ISSN:1120-009X

T. Mazzei; E. Mini; M. Eandi; E. F. Reali; L. Fioretto; R. Bartoletti; M. Rizzo; G. Calabrò; P. Periti (1989). Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation.. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, vol. 15, pp. 373-387, ISSN:0378-6501

P. Periti; T. Mazzei; F. Tonelli (1989). Single-dose cefotetan vs. multiple-dose cefoxitin--antimicrobial prophylaxis in colorectal surgery. Results of a prospective, multicenter, randomized study.. DISEASES OF THE COLON & RECTUM, vol. 32, pp. 121-127, ISSN:0012-3706

Stanyon R.; Mini E.; Coronnello M.; Gerli A.; Mazzei T.; Periti P. (1989). Analisi cariologica di linee cellulari leucemiche umane CCRF-CEM resistenti al metotressato (MTX) per alterata poliglutammilazione.. TUMORI, vol. 75/suppl.4, pp. 53-53, ISSN:0300-8916

P. Periti; T. Mazzei; E. Mini; A. Novelli (1989). Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).. CLINICAL PHARMACOKINETICS, vol. 16 (5), pp. 261-282, ISSN:0312-5963

P. Periti; T. Mazzei; F. Orlandini; E. Mini (1988). Comparison of the antimicrobial prophylactic efficacy of cefotaxime and cephazolin in obstetric and gynaecological surgery. A randomised multicentre study.. DRUGS, vol. 35 Suppl 2, pp. 133-138, ISSN:0012-6667

Mini E, Mazzei T, Rizzo M, Periti P (1988). Pharmacokinetics and endocrine effects of leuprolide depot. In: 6th Mediterranean Congress of Chemotherapy, Taormina-Giardini Naxos, Italy, Maggio 22-27, 1988, -, pp. 69-69.

Novelli A, Mazzei T, Reali EF, Balocchini E, Melani A, Mini E, Periti P (1988). Clinical pharmacokinetics and tissue penetration of teicoplanin. In: 8th International Symposium on Future Trends in Chemotherapy, Tirrenia, Pisa, Italy, Marzo 28-30, 1988, -, pp. 203-203.

Mazzei T, Mini E, Eandi M, Reali EF, Fioretto L, Magni M, Periti P (1988). Pharmacokinetics and endocrine effects of leuprolide depot in advanced prostatic cancer: a dose-response analysis. In: 8th International Symposium on Future Trends in Chemotherapy, Tirrenia, Pisa, Italy, Marzo 28-30, 1988, -, pp. 204-204.

Mini E, Mazzei T, Periti P (1988). Pharmacokinetics and metabolism of hormonal drugs: clinical implications. In: International Symposium of Hormonotherapy in Oncology, Bologna, Italy,, Marzo 23-25, 1988, -, pp. 1988-1988.

D.Martinelli;T.Mazzei;S.Fallani;G.Palendri;A.Novelli;P.Periti (1988). Ceftizoxime concentrations in human aqueous humor following intravenous administration.. CHEMIOTERAPIA, vol. 7, pp. 317-319, ISSN:0392-906X

P.Periti; T.Mazzei; E.Periti (1988). Prophylaxis in gynecological and obstetric surgery: a comparative randomized multicenter study of single dose cefotetan versus two doses of ceefazolin. CHEMIOTERAPIA, vol. 7, pp. 245-252, ISSN:0392-906X

E. Mini; G. Pizzorno; M. Coronnello; J. J. McGuire; T. Mazzei; P. Periti; J. R. Bertino (1988). Impaired methotrexate polyglutamylation in a human leukemia cell line resistant to short-term, high-dose methotrexate.. PHARMACOLOGICAL RESEARCH COMMUNICATIONS, vol. 20, pp. 445-446, ISSN:0031-6989

G. Pizzorno; E. Mini; M. Coronnello; J. J. McGuire; B. A. Moroson; A. R. Cashmore; R. N. Dreyer; J. T. Lin; T. Mazzei; P. Periti; J.R Bertino (1988). Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug.. CANCER RESEARCH, vol. 48, pp. 2149-2155, ISSN:0008-5472

Mini E.; Mazzei T.; Coronnello M.; Bertino J.R.; Periti P (1988). Compa¬rative effects of two non-classical antifolates, tri¬metrexate (TMQ) and triazinate (TZT), on 5-fluoroura¬cil (FUra) cytotoxicity against human CCRF-CEM leukemia cells.. ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH PROCEEDINGS, vol. 29, pp. 475-475, ISSN:0197-016X

E. Mini; T. Mazzei; M. Coronnello; L. Criscuoli; M. Gualtieri; P. Periti; J. R. Bertino (1987). Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells.. BIOCHEMICAL PHARMACOLOGY, vol. 36, pp. 2905-2911, ISSN:0006-2952

P.Periti; T.Mazzei (1987). Principles of antimicrobial chemoprophylaxis in surgery. CHEMIOTERAPIA, vol. 6, pp. 196-201, ISSN:0392-906X

E.Mini; T.Mazzei; P.Periti; E.F.Reali; P.Bordonaro; E.Balocchini; B.Ninu (1987). Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin. CHEMIOTERAPIA, vol. 6, pp. 243-246, ISSN:0392-906X

P.Periti; T.Mazzei; P.Nicoletti (1987). Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates. CHEMIOTERAPIA, vol. 6, pp. 75-78, ISSN:0392-906X

P.Periti;T.Mazzei;A.Novelli;E.F.Reali;P.Nicoletti (1987). Ciprofloxacin inhibition of cefoxitin betalactamase induction in an Enterobacter cloacae strain.. CHEMIOTERAPIA, vol. 6, pp. 251-255, ISSN:0392-906X

Periti P, Mini E, Mazzei T, Fioretto L, Magni M, Bartoletti R, Rizzo M (1987). Preliminary results of a phase II multicenter study on the clinical efficacy and safety to the LH-RH analog leuprolide in the treatment of prostatic carcinoma. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, vol. 10, pp. 53-53, ISSN:0391-4097

Periti P, Mazzei T, Orlandini F, Mini E (1987). Comparative randomized multicenter study of cefotetan and cefazolin i.v. as antimicrobial prophylaxis in gynecological and obstetric surgery. In: International Symposium on the Control of Hospital Infections, Rome, Italy, Aprile 27-29, 1987, -, pp. 118-118.

Mini E, Pizzorno G, Mazzei T, Moroson BA, Cashmore AR, Bertino JR (1987). Impaired polyglutamylation as a mechanism of resistance to methotrexate (MTX) in human leukemia CCRF-CEM cells to high-dose short-term exposure to this drug. In: 78th Annual Meeting of the American Association for Cancer Research, Atlanta, GE, USA, Maggio 20-23, 1987, American Association for Cancer Research, pp. 285-285.

Periti P, Mazzei T, Novelli A, Reali EF, Mini E (1987). Comparative tissue penetration of betalactam antibiotics. In: International Symposium on the Control of Hospital Infections, Rome, Italy, Aprile 27-29, 1987, -, pp. 113-113.

Mini, E; Mazzei, T; Periti, P; Reali, E F; Bordonaro, P; Balocchini, E; Ninu, B (1987). Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin. CHEMIOTERAPIA, vol. 6, pp. 243-246, ISSN:0392-906X

Mini E, Mazzei T, Palminiello A, Bordonaro P, Mazzola L, Periti P (1987). Tissue penetration of the new macrolide roxithromycin (RU 28965, ROX) into the lung. In: 15th International Congress of Chemotherapy, Istanbul, Turkey, Luglio 19-24, 1987, -, pp. 102-102.

Bernabei PA, Mini E, Agostino FC, Gattei V, Bezzini ER, Santini V, Saccardi R, Mazzei T, Rossi Ferrini P (1987). 5-methyltetrahydrofolate (mTHF) induces monocytes differentiation in HL60 cells. In: 4th International Symposium on Therapy of Acute Leukemias, Rome, Italy, Febbraio 7-12, 1987, -, pp. 458-458.

P. Periti; T. Mazzei (1987). Pharmacokinetics of roxithromycin in renal and hepatic failure and drug interactions.. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 20 Suppl B, pp. 107-112, ISSN:0305-7453

E. Mini; T. Mazzei; M. Coronnello; L. Criscuoli; M. Gualtieri; P. Periti (1986). Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines. In: 14th International Cancer Congress, Budapest, Hungary, Au¬gust 21-27, 1986, vol. A, pp. 393-393.

Martoni A, Mazzei T, Mini E, Fioretto L, Miseria S, Preti P, Cellerino R, Pannuti F, Robustelli Della Cuna G, Periti P (1986). Phase I trial of a novel alkylating agent. CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. 23, pp. 48-48, ISSN:0344-5704

Mini E.; Mazzei T.; Coronnello M.; Gualtieri M.; Cri¬scuoli L.; Periti P (1986). Sviluppo di linee cellulari leu¬cemiche umane resistenti al metotres¬sato (MTX). Ri¬sultati preliminari con un modello in studio in vitro alternativo. TUMORI, vol. 72/suppl.6, pp. 670-670, ISSN:0300-8916

Mini E.; Mazzei T.; Gualtieri M.; Criscuoli L.; Coronnello M.; Periti P (1986). Citotossicità comparativa del 3-(p-fluorofenil)-L-alanilmetionina etilestere clori¬drato, PTT-119, e del melfalan (L-PAM) in cellule tu¬morali umane.. TUMORI, pp. 670-670, ISSN:0300-8916

F.Gasparri; P.Periti; G.Scarselli; T.Mazzei; L.Savino; F.Branconi; R.G.Dancygier (1986). Perioperative chemotherapy in thet reatment of carcinoma of the uterine cervix. CHEMIOTERAPIA, vol. 5, pp. 44-52, ISSN:0392-906X

Mini E, Mazzei T, Coronnello M, Criscuoli L, Gualtieri M, Periti P (1986). Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines. In: 14th International Cancer Congress, Budapest, Hungary, Agosto 21-27, 1986, -, pp. 393-393.

Periti P, Mazzei T, Mini E, Fioretto L, Pannuti F, Martoni A, Cellerino R, Miseria S (1986). Phase I clinical trial of a new alkylating agent, PTT-119. In: 14th International Cancer Congress, Budapest, Hungary, Agosto 21-27, 1986, -, pp. 454-454.

P. Periti; T. Mazzei (1985). Infections in immunocompromised patients. II. Established therapy and its limitations.. CLINICAL THERAPEUTICS, vol. 8, pp. 100-117, ISSN:0149-2918

Mini, E; Mazzei, T; Coronnello, M; Criscuoli, L; Gualtieri, M; Periti, P (1985). Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM. CHEMIOTERAPIA, vol. 4, pp. 454-459, ISSN:0392-906X

Mazzei T, Mini E, Periti P (1985). 5-methyltetrahydrofolate (MeTHF) enhances fluoropyrimidine cytotoxicity against human leukemia cells in vitro. BRITISH JOURNAL OF PHARMACOLOGY, vol. 86, pp. 561-561, ISSN:0007-1188

Periti P, Robustelli Della Cuna G, Pannuti F, Mazzei T, Preti P, Martoni A, Mini E (1985). Mitoxantrone (dihydro-anthracenedione, DHAD) combined with cyclophosphamide (CYC) as first line chemotherapy in advanced breast cancer. In: 3rd European Conference on Clinical Oncology and Cancer Nursing, Stockholm, Sweden, Giugno 16-20, 1985, -, pp. 82-82.

Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P. (1985). Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM.. CHEMOTHERAPY, vol. 4, pp. 454-459, ISSN:0009-3157

Mini E, Mazzei T, Periti P (1985). Fluoropyrimidine-folate synergy in human leukemia-lymphoma cells in culture. In: 3rd European Conference on Clinical Oncology and Cancer Nursing, Stockholm, Sweden, Giugno 16-20, 1985, -, pp. 127-127.

P. Periti; G. R. della; F. Pannuti; T. Mazzei; P. Preti; A. Martoni; E. Mini (1985). First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer.. INVESTIGATIONAL NEW DRUGS, vol. 3, pp. 167-171, ISSN:0167-6997

T.Mazzei; M.Bonazza; G.Amunni; G.Scarselli; F.Branconi; G.B.Massi (1984). Polychemotherapy in ovarian cancer: treatment with adriamycin, BCNU and cyclophosphamide vs. adrianycin and cyclophosphamide. CHEMIOTERAPIA, vol. 3, pp. 10-15, ISSN:0392-906X

E. Mini ; T. Mazzei ; M. Coronnello ; L. Criscuoli ; M. Gualtieri ; P. Periti (1984). Modulation of fluoropyrimidine cytotoxicity by methotrexate or5-methyltetrahydrofolate in human leukemia cells in vitro. CHEMOTHERAPY, vol. 3, pp. 343-349, ISSN:0009-3157

P.Periti; T.Mazzei; A.Costantini; M.Rizzo; F.Gasparri; G.Scarselli; E.Alajmo; O.Finistorchi; P.Nicoletti (1984). Comparative pharmacokinetic evaluation of ceftriaxone and cefotaxime in coincidence for short-term antimicrobial prophylaxis in surgery. CHEMIOTERAPIA, vol. 3, pp. 305-309, ISSN:0392-906X

P.Periti; T.Mazzei; S.Lamanna; E.Mini (1984). Single-dose ceftriaxone versus multi-dose cefotaxime as short-term antimicrobial prophylaxis in urologic surgery. Preliminary results of a multicenter prospective randomized study. CHEMIOTERAPIA, vol. 3, pp. 295-298, ISSN:0392-906X

T.Mazzei (1984). Chemistry and mechanism of action of bleomycin. CHEMIOTERAPIA, vol. 3, pp. 316-319, ISSN:0392-906X

T.Mazzei; C.Marino; F.Nozzoli; A.Lopes-Pegna; R.Righi; C.Santomaggio; S.Lamanna; P.Periti (1984). Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma. CHEMIOTERAPIA, vol. 3, pp. 16-18, ISSN:0392-906X

M.C.Lagomarsino Caprino; T.Mazzei; L. De Vecchis; P.Popoli; P.Periti (1984). Preliminary research on the evaluation of some prognostic factors in a randomized study of adjuvant immunochemotherapy in colorectal adenocarcnoma. CHEMIOTERAPIA, vol. 3, pp. 3-9, ISSN:0392-906X

P.Periti; T.Mazzei; S.Lamanna; E.Mini (1984). Single-dose ceftriaxone vs. multiple-dose cefotaxime antimicrobial prophylaxis in gynecologic and obstetrical surgery. Preliminary results of a multicenter propsective randomized study. CHEMIOTERAPIA, vol. 3, pp. 299-304, ISSN:0392-906X

Mazzei T, Rizzo M, Scarselli G, Mini E (1984). Single-dose ceftriaxone versus multiple-dose cefotaxime antimicrobial prophylaxis in urologic, gynecologic, and obstetrical surgery. A multicenter study. In: 6th International Symposium on Future Trends in Chemotherapy, Tirrenia, Pisa, Italy, Maggio 28-30, 1984, -, pp. 129-129.

A. Novelli; T. Mazzei; C. Vallecchi; E.F. Reali; L. Trombi Belcari; S. Moretti; B. Giannotti (1983). Valutazione immunologica in corso di immunochemioterapia del melanoma. CHEMIOTERAPIA, vol. 2, pp. 244-246, ISSN:0392-906X

T.MAZZEI;G.SCARSELLI;M.CIUFFI;L.SAVINO;G.SPINELLI;A.NOVELLI;M.LUERTI;A.BENINI;P.PERITI (1983). Oral medroxyprogesterone acetate pharmacokinetics: results in a group of patients during a controlled clinical trial on stage I endometrial carcinoma.. CHEMIOTERAPIA, vol. 2 (4), pp. 222-225, ISSN:0392-906X

A.NOVELLI;M.CIUFFI;U.M.REALI;T.MAZZEI;P.PERITI (1983). The suction blister technique as a tool in antimicrobial drug pharmacokinetics.. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, vol. 9 (7), pp. 555-559, ISSN:0378-6501

A.NOVELLI;U.M.REALI;M.CIUFFI;T.MAZZEI;E.F.REALI;M.SALVADORI;A.ATTARDI;P.PERITI (1983). Moxalactam pharmacokinetics in healthy volunteers and patients with renal insufficiency.. CHEMIOTERAPIA, vol. 2 (1), pp. 30-37, ISSN:0392-906X

A.NOVELLI;T.MAZZEI;M.CIUFFI;P.NICOLETTI;P.BUZZONI;E.F.REALI;P.PERITI (1983). The penetration of intramuscular cefotetan disodium into human extravascular fluid and maternal milk secretion.. CHEMIOTERAPIA, vol. 2 (5), pp. 337-342, ISSN:0392-906X

Periti P.; Ciuffi M.; Coronnello M.; Mazzei T; Mini E (1983). Pharmacokinetics of 5-methyltetrahydrofolate in normal adults. CHEMIOTERAPIA, vol. 2, pp. 83-87, ISSN:0392-906X

Mazzei T, Cavallo AM, Branconi F, Mini E, Di Gioia E (1982). Ovarian epithelial carcinoma: treatment with cisplatinum + VP16. CHEMIOTERAPIA, vol. 1, pp. 119-119, ISSN:0392-906X

Periti P, Mazzei T, Ciuffi M, Savino L, Spinelli G, Mini E (1982). Pharmacokinetics of oral medroxyprogesterone acetate at moderate doses.. CHEMIOTERAPIA, vol. 1, pp. 126-126, ISSN:0392-906X

Mini E.; Mazzei T.; Nicoletti P. (1981). Cefazolin/dicloxacillin combination: experimental and clinical aspects. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, vol. 7, pp. 585-589, ISSN:0378-6501

Nicita G; Nicoletti P; Mazzei T; Rizzo M (1981). Intra-operative antibiotic perfusion in the renal artery in patients with infection induced staghorn calculi. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, vol. 7, pp. 545-548, ISSN:0378-6501

Mazzei T.; Ciuffi M.; Cavallo A.M.;Mini E, Nicoletti P, Bonazza M, Catalani C, Coronnello M. (1981). Bacteriological, pharmacokinetic and clinical evaluation of bekanamycin. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, vol. 7, pp. 489-494, ISSN:0378-6501

Mazzei T, Ciuffi M, Mini E, Bonazza M (1980). Bacampicillin and talampicillin serum and urinary levels when the two antibiotics have been given orally at equimolar doses of ampicillin. In: 4th International Symposium on Future Trends in Chemotherapy, Florence, Italy, Giugno 23-24, 1980, -, pp. 121-121.

Mini E, Mazzei T, Schiatti R, Cavallo AM, Carini M, Rizzo M. (1980). Cefazolin/dicloxacillin combination in the treatment of urinary tract infections. In: 4th International Symposium of Future Trends in Chemotherapy, Florence, Italy, Giugno 23-24, 1980, -, pp. 81-81.

Mazzei T, Mini E, Nicoletti P, Ciuffi M, Carini M, Bertoni E, Coronnello M, Mainardi GC, Amato M (1980). Bacteriological, pharmacokinetic and clinical study of dibekacin. In: 4th International Symposium on Future Trends in Chemotherapy, Florence, Italy, Giugno 23-24, 1980, -, pp. 69-69.

Mazzei T, Ciuffi M, Mini E, Nicoletti P, Cavallo AM, Bonazza M, Catalani C, Criscuoli L (1980). Bacteriological, pharmacokinetic and clinical evaluation of bekanamycin. In: 4th International Symposium on Future Trends in Chemotherapy, Florence, Italy, Giugno 23-24, 1980, -, pp. 68-68.

P.PERITI;T.MAZZEI;E.MINI;A.NOVELLI;P.NICOLETTI;A.LAMANNA (1979). High dose fosfomycin: indications, tolerance and pharmacokinetics.. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, vol. 5 (2-3), pp. 373-377, ISSN:0378-6501

T. Mazzei; E. Mini; A.M. Cavallo; M. Carini; M. Bonazza; G.C. Vannozzi; G. Zuccati (1979). Chemioterapia oncologica e controllo del dolore cronico mediante farmaci analgesics non narcotics: il ruolo del diflunisal. CHEMIOTERAPIA ONCOLOGICA, vol. anno III, vol 2, pp. 92-109, ISSN:0392-0968

Rizzo M, De Carlo G, Amato M, Parri F, Lamanna S, Mini E, Mazzei T (1979). Cefamandole pharmacokinetics in man. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, vol. 5, pp. 141-152, ISSN:0378-6501

M.Rizzo;C.Bartolozzi;D.CAMMELLI;M.FRANCHINI;G.DE CARLO;G.C.MAINARDI;T.REPETTO;F.PARRI;T.MAZZEI;S.LAMANNA;E.MINI;A.NOVELLI (1979). Clinical pharmacology of bacampicillin: a multidisciplinary study.. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, vol. 5 (2-3), pp. 27-32, ISSN:0378-6501

A.LAMANNA;P.NICOLETTI;A.NOVELLI;E.MINI;S.MAZZOLI;T.MAZZEI (1979). Dibekacin in vitro activity on recently isolated bacterial strains from various clinical materials.. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, vol. 5 (2-3), pp. 259-263, ISSN:0378-6501

P. Nicoletti; A. Novelli; G. Landini; M. Ruggers; T. Mazzei; E. Mini; G. De Carlo; A.M. Cavallo; M. Rizzo; G. Zuccati (1978). Osservazioni laboratoristiche e cliniche sul sinergismo fra fosfomicina e beta lattamine. CHEMIOTERAPIA ANTIMICROBICA, vol. 3, pp. 341-353, ISSN:0391-9862

T. Mazzei; M. Paradiso; I. Nicoletti; P. Periti (1976). Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies.. THE JOURNAL OF INFECTIOUS DISEASES, vol. 134 SUPPL, pp. S374-S379, ISSN:0022-1899

Teresita MAZZEI

Teresita MAZZEI

Teresita MAZZEI

Teresita MAZZEI

Insegnamenti relativi all'Anno Accademico 2017-2018 2016-2017 2015-2016 2014-2015 2013-2014 2012-2013 2011-2012 2010-2011 2009-2010 2008-2009 2007-2008

Insegnamenti relativi all'Anno Accademico